<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">82626</article-id><article-id pub-id-type="doi">10.7554/eLife.82626</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>Targeted multi-omic analysis of human skin tissue identifies alterations of conventional and unconventional T cells associated with burn injury</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-289502"><name><surname>Labuz</surname><given-names>Daniel R</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3769-3544</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-289506"><name><surname>Lewis</surname><given-names>Giavonni</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-289503"><name><surname>Fleming</surname><given-names>Irma D</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-289504"><name><surname>Thompson</surname><given-names>Callie M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-289505"><name><surname>Zhai</surname><given-names>Yan</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-16830"><name><surname>Firpo</surname><given-names>Matthew A</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-69902"><name><surname>Leung</surname><given-names>Daniel T</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8401-0801</contrib-id><email>daniel.leung@utah.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03r0ha626</institution-id><institution>Division of Infectious Disease, Department of Internal Medicine, University of Utah</institution></institution-wrap><addr-line><named-content content-type="city">Salt Lake City</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03r0ha626</institution-id><institution>Division of Microbiology &amp; Immunology, Department of Pathology, University of Utah</institution></institution-wrap><addr-line><named-content content-type="city">Salt Lake City</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03r0ha626</institution-id><institution>Department of Surgery, School of Medicine, University of Utah</institution></institution-wrap><addr-line><named-content content-type="city">Salt Lake City</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Kim</surname><given-names>Brian S</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Icahn School of Medicine at Mount Sinai</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Zaidi</surname><given-names>Mone</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Icahn School of Medicine at Mount Sinai</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>15</day><month>02</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e82626</elocation-id><history><date date-type="received" iso-8601-date="2022-08-11"><day>11</day><month>08</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-01-27"><day>27</day><month>01</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-09-01"><day>01</day><month>09</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.08.30.505800"/></event></pub-history><permissions><copyright-statement>© 2023, Labuz et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Labuz et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-82626-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-82626-figures-v1.pdf"/><abstract><p>Burn injuries are a leading cause of unintentional injury, associated with a dysfunctional immune response and an increased risk of infections. Despite this, little is known about the role of T cells in human burn injury. In this study, we compared the activation and function of conventional T cells and unconventional T cell subsets in skin tissue from acute burn (within 7 days from initial injury), late phase burn (beyond 7 days from initial injury), and non-burn patients. We compared T cell functionality by a combination of flow cytometry and a multi-omic single-cell approach with targeted transcriptomics and protein expression. We found a significantly lower proportion of CD8+ T cells in burn skin compared to non-burn skin, with CD4+ T cells making up the bulk of the T cell population. Both conventional and unconventional burn tissue T cells show significantly higher IFN-γ and TNF-α levels after stimulation than non-burn skin T cells. In sorted T cells, clustering showed that burn tissue had significantly higher expression of homing receptors CCR7, S1PR1, and SELL compared to non-burn skin. In unconventional T cells, including mucosal-associated invariant T (MAIT) and γδ T cells, we see significantly higher expression of cytotoxic molecules GZMB, PRF1, and GZMK. Multi-omics analysis of conventional T cells suggests a shift from tissue-resident T cells in non-burn tissue to a circulating T cell phenotype in burn tissue. In conclusion, by examining skin tissue from burn patients, our results suggest that T cells in burn tissue have a pro-inflammatory rather than a homeostatic tissue-resident phenotype, and that unconventional T cells have a higher cytotoxic capacity. Our findings have the potential to inform the development of novel treatment strategies for burns.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>burn injury</kwd><kwd>Unconventional T cells</kwd><kwd>skin</kwd><kwd>MAIT cells</kwd><kwd>Conventional T cells</kwd><kwd>single-cell omics</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01AI130378</award-id><principal-award-recipient><name><surname>Leung</surname><given-names>Daniel T</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>TL1TR002540</award-id><principal-award-recipient><name><surname>Labuz</surname><given-names>Daniel R</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Compared to non-burn tissue, T cells in burn tissue have a pro-inflammatory rather than a homeostatic tissue-resident phenotype, and unconventional T cells in burn tissue have a higher cytotoxic capacity.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Burn injuries are a major health issue globally, ranking among the leading causes of unintentional injury, and non-surgical treatment options are mostly limited to supportive clinical care (<xref ref-type="bibr" rid="bib44">Peck, 2011</xref>; <xref ref-type="bibr" rid="bib7">Boldeanu et al., 2020</xref>). Major burn trauma results in dysfunctional immune responses and is associated with an increased risk of infections leading to poor survival outcomes (<xref ref-type="bibr" rid="bib41">Moins-Teisserenc et al., 2021</xref>; <xref ref-type="bibr" rid="bib4">Bergquist et al., 2019</xref>; <xref ref-type="bibr" rid="bib25">Jeschke et al., 2014</xref>). Serum levels of interleukin (IL)–6, IL-10, tumor necrosis factor (TNF)-α, and interferon (IFN)-γ are significantly higher in burn trauma patients compared to non-burn (<xref ref-type="bibr" rid="bib36">Mace et al., 2012</xref>; <xref ref-type="bibr" rid="bib16">Finnerty et al., 2007</xref>). Similarly, higher serum concentrations of IL-6, IL-8, IL-10, GM-CSF, IL-12p70, IFN-γ, and TNF-α, are associated with sepsis and death in children with severe burns (<xref ref-type="bibr" rid="bib16">Finnerty et al., 2007</xref>). Despite the many studies in this area that examine immune responses in blood to understand the systemic effects of burn injury, there is a paucity of studies examining the local immune response of injured burn tissue in humans.</p><p>Most reports characterizing T cells in the skin after a burn injury have been in mice (<xref ref-type="bibr" rid="bib13">Daniel et al., 2007</xref>; <xref ref-type="bibr" rid="bib47">Rani et al., 2015</xref>; <xref ref-type="bibr" rid="bib49">Sasaki et al., 2011</xref>; <xref ref-type="bibr" rid="bib48">Rani and Schwacha, 2017</xref>). In particular, αβ T cells and gamma-delta (γδ) T cells show increased production of cytokines TNF-α, IL-10, and IFN-γ in the days following burn injury (<xref ref-type="bibr" rid="bib46">Rani et al., 2014</xref>). A significant number of αβ T cells and γδ T cells infiltrate the burn site, causing a total decrease in CD69+ cells, a marker of tissue residency in T cells (<xref ref-type="bibr" rid="bib47">Rani et al., 2015</xref>; <xref ref-type="bibr" rid="bib50">Schenkel and Masopust, 2014</xref>). Knockout of γδ T cells results in significantly higher TNF-α levels in the skin of mice following burn injury, suggesting a major role of γδ T cells in negating a pro-inflammatory environment (<xref ref-type="bibr" rid="bib13">Daniel et al., 2007</xref>). However, given the discrepancy in the proportion of skin-resident γδ T cells between mice (where they account for &gt;50% of total T cells) and humans (accounting for 2–5% of total T cells, <xref ref-type="bibr" rid="bib14">Ebert et al., 2006</xref>; <xref ref-type="bibr" rid="bib40">Mestas and Hughes, 2004</xref>), the clinical significance of the above findings is yet to be determined (<xref ref-type="bibr" rid="bib52">Schwacha, 2009</xref>). In addition, while circulating T cells following burn injury in humans have elevated activation markers such as CD25 and HLA-DR (<xref ref-type="bibr" rid="bib41">Moins-Teisserenc et al., 2021</xref>), the role of local or skin-resident T cells in human burn injury and burn-associated wound healing has not been well-studied.</p><p>Tissue-resident memory T cells (T<sub>RM</sub>) in normal skin are effector memory cells that can persist for several years following an infection (<xref ref-type="bibr" rid="bib9">Clark et al., 2006</xref>; <xref ref-type="bibr" rid="bib62">Zaid et al., 2014</xref>). Thus, upon activation, skin T<sub>RM</sub> are potent producers of cytokines IFN-γ, IL-10, and TNF-α (<xref ref-type="bibr" rid="bib9">Clark et al., 2006</xref>; <xref ref-type="bibr" rid="bib10">Clark et al., 2012</xref>). Skin T<sub>RM</sub> are characterized by their high expression of CD103 (encoded by ITGAE) and CD69, and low expression of S1PR1, which allows them to persist in the skin by inhibiting the egress and circulation of cells to skin draining lymph nodes (<xref ref-type="bibr" rid="bib11">Clark, 2015</xref>; <xref ref-type="bibr" rid="bib53">Shiow et al., 2006</xref>). In comparison, skin central-memory T cells (T<sub>CM</sub>), which recirculate between blood and ski (<xref ref-type="bibr" rid="bib10">Clark et al., 2012</xref>), express CCR7 and CD62L (encoded by SELL). The impact of acute inflammatory insults such as burns on T<sub>RM</sub> and T<sub>CM</sub> populations remains unknown.</p><p>Mucosal-associated invariant T (MAIT) cells, a recently discovered unconventional innate-like T cell subset, have been shown to have capacity to participate in tissue repair (<xref ref-type="bibr" rid="bib12">Constantinides et al., 2019</xref>; <xref ref-type="bibr" rid="bib22">Hinks et al., 2019</xref>; <xref ref-type="bibr" rid="bib33">Leng et al., 2019</xref>; <xref ref-type="bibr" rid="bib32">Lamichhane et al., 2019</xref>). MAIT cells express a semi-invariant T cell receptor (TCR)-α consisting primarily of TRAV1-2 in humans and a variant but restricted variety of β chains. MAIT cells can be activated through a TCR-dependent pathway through presentation of a microbial-derived riboflavin metabolite, 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil (5-OP-RU), by MHC class-1 related protein (MR1) on antigen-presenting cells (APC) (<xref ref-type="bibr" rid="bib27">Kjer-Nielsen et al., 2012</xref>). MAIT cells can also be activated through a TCR-independent manner through cytokines IL-12, IL-15, and IL-18 (<xref ref-type="bibr" rid="bib59">van Wilgenburg et al., 2016</xref>). Upon activation, MAIT cells express a variety of cytokines, including IFN-γ, TNF-α, IL17A, and IL-22 (<xref ref-type="bibr" rid="bib18">Gibbs et al., 2017</xref>). The type of cytokine expressed is primarily influenced by the environment with peripheral blood MAIT cells expressing pro-inflammatory cytokines IFN-γ and TNF-α and tissue-resident MAIT cells expressing IL-17A and IL-22 (<xref ref-type="bibr" rid="bib18">Gibbs et al., 2017</xref>). The wound healing capacity of human MAIT cells has been hypothesized to be a function of cytokine expression involving IL-17A and IL-22 pathways (<xref ref-type="bibr" rid="bib12">Constantinides et al., 2019</xref>; <xref ref-type="bibr" rid="bib33">Leng et al., 2019</xref>). In mice, it was shown that skin MAIT cells, when activated with a topical 5-OP-RU MAIT ligand, can promote tissue repair through an IL-17A pathway (<xref ref-type="bibr" rid="bib12">Constantinides et al., 2019</xref>). Despite their suggested role in tissue repair, the activity of MAIT cells in burn tissue has yet to be determined.</p><p>Given the knowledge gap around the role of T cells in human burn injury, our primary objective was to examine the landscape of conventional and unconventional T cells following burn injury. We used flow cytometry to analyze the cytokine profiles of conventional T cells and unconventional T cells including MAIT and γδ T cells. We compared populations of CD3+ cells within non-burn and burn tissue using a targeted T-cell panel with single-cell RNA sequencing (scRNA-seq) to determine specific subsets of T cells within the tissue and their gene expression profiles. We found that conventional CD3+ T cells and MAIT cells in burn-injured skin tissue produce higher levels of critical pro-inflammatory cytokines than in non-burn tissue. We also found that burn tissue T cell populations express higher levels of homing receptors associated with tissue residency, including S1PR1, SELL, and CCR7 compared to non-burn tissue T cells.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Conventional CD8+ T cell populations are lower and conventional CD4+ T cell populations are higher in burn tissue compared to non-burn tissue</title><p>We used flow cytometry to determine the phenotype and frequency of T cell populations in burn tissue (12 samples, 11 subjects, 11.0% ± 7.4% TBSA), and non-burn tissue (7 samples, 7 subjects, 10.4%±4.7 TBSA; <xref ref-type="fig" rid="fig1">Figure 1A</xref>, <xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>). Acute burn tissue samples (discarded tissue via tangential excision) were collected from patients within 7 days of initial injury, while late phase burn tissue was collected beyond 7 days of initial injury. Five non-burn tissue samples were collected from discarded split thickness autografts of acute burn patients (labeled ‘acute non-burn’ in <xref ref-type="table" rid="table1">Table 1</xref>), whereas two non-burn tissue samples were from patients who were undergoing surgeries not related to acute burn injuries (labeled ‘non-burn’ in <xref ref-type="table" rid="table1">Table 1</xref>). CD3+ T cells’ frequency as proportion of live cells (<xref ref-type="fig" rid="fig1">Figure 1B and C</xref>) and total cell counts (<xref ref-type="fig" rid="fig1">Figure 1D</xref>), were not significantly different in any tissue comparison. We found a significantly higher proportion of CD4+ T cells in burn tissue (median 62.3% [interquartile range, IQR, 46.2%–70.9%]) compared to non-burn tissue (35.4% [18.6%–41.2%]; <xref ref-type="fig" rid="fig1">Figure 1E</xref>, p=0.02), while we saw lower proportion of CD8+ T cells in burn tissue (23.0% [18.9%–26.0%], p&lt;0.0001) compared to non-burn tissue (53.4% [44.5%–69.6%]) (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). We did not see any significant differences in absolute numbers of CD4+ or CD8+ T cells between burn and non-burn skin. (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B, C</xref>). In unconventional CD3+ T cell populations, there were no significant differences in proportions of Vα24-Jα18+ iNKT cells (<xref ref-type="fig" rid="fig1">Figure 1G and H</xref>), TCRγ<italic>δ+</italic> T cells (<xref ref-type="fig" rid="fig1">Figure 1G1</xref>), and MR1-5-OP-RU-tetramer+TRAV1-2+ MAIT cells (<xref ref-type="fig" rid="fig1">Figure 1J and K</xref>), between burn tissue and non-burn tissue. We analyzed separately the ‘acute burn’ and ‘acute non-burn’ groups, and showed similar differences between these groups for both CD8+and CD4+ populations (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Taken together, we found a markedly lower proportion of conventional CD8+ T cells and a higher proportion of CD4+ T cells in burn tissue compared to non-burn tissue, but no differences were seen in the proportions of unconventional T cells.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Conventional CD8 +T cell populations are lower and CD4 +T cells populations are higher in burn tissue compared to non-burn tissue.</title><p>Overview of the processing and analysis of T cells in burn and non-burn skin tissue for flow cytometry (<bold>A</bold>). Representative gating of CD3+, CD4+ and CD8+ T cells from live cells from non-burn tissue and burn tissue (<bold>B</bold>). Frequency of CD3+ T cells from live cells in burn or non-burn tissue measured by flow cytometry (<bold>C</bold>). Absolute count of CD3+ T cells from specific volume of burn or non-burn tissue measured by flow cytometry (<bold>D</bold>). Frequency of CD8+ and CD4+ T cells by flow cytometry (<bold>E–F</bold>). Frequency and gating strategy of unconventional T cell populations: iNKT (<bold>G,H</bold>), γδ T cells (<bold>G,I</bold>), or MAIT cells (<bold>J,K</bold>). Error bars shown are of median with interquartile range. Differences between burn and non-burn were calculated using Mann-Whitney <italic>U</italic> test with *p&lt;0.05, ** p&lt;0.01, ****p&lt;0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82626-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Conventional CD8+ T cell populations are lower and CD4+ T cells populations are higher in acute burn tissue compared to acute non-burn tissue.</title><p>Frequency of CD3+ T cells from live cells in burn or non-burn tissue measured by flow cytometry (<bold>A</bold>). Absolute count of CD3+ T cells from specific volume of burn or non-burn tissue measured by flow cytometry (<bold>B</bold>). Frequency of CD8+ and CD4+ T cells by flow cytometry (<bold>C,D</bold>). Frequency and gating strategy of unconventional T cell populations: iNKT (<bold>E</bold>), γδ T cells(F), or MAIT cells (<bold>G</bold>). Error bars shown are of median with interquartile range. Differences between groups were calculated using Mann-Whitney <italic>U</italic> test with *p&lt;0.05, **p&lt;0.01.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82626-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Conventional CD4+ and CD8+ T cell absolute numbers are not significantly different between burn and non-burn tissue.</title><p>Gating strategy used in this paper, from forward scatter by side scatter, of conventional and unconventional T cells (<bold>A</bold>). Absolute number of live CD4+ and CD8+ T cells per mm<sup>3</sup> in burn and non-burn tissues (<bold>B–C</bold>). Error bars shown are of median with interquartile range. Differences between burn and non-burn were calculated using Mann-Whitney <italic>U</italic> test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82626-fig1-figsupp2-v1.tif"/></fig></fig-group><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Demographics of patients used in this study.</title><p>n/a implies the skin sample came from a patient who was not a severe burn patient or several years past initial burn injury.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Age group</th><th align="left" valign="bottom">Sex</th><th align="left" valign="bottom">Type</th><th align="left" valign="bottom">TBSA</th><th align="left" valign="bottom">Days sample taken after burn</th><th align="left" valign="bottom">Type of injury</th><th align="left" valign="bottom">Category</th></tr></thead><tbody><tr><td align="char" char="ndash" valign="bottom">70–79</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Burn</td><td align="char" char="." valign="bottom">16</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Flame</td><td align="left" valign="bottom">Acute Burn</td></tr><tr><td align="char" char="ndash" valign="bottom">30–39</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Burn</td><td align="char" char="." valign="bottom">9</td><td align="left" valign="bottom">11</td><td align="left" valign="bottom">Scald</td><td align="left" valign="bottom">Late Phase Burn</td></tr><tr><td align="char" char="ndash" valign="bottom">60–69</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Burn</td><td align="char" char="." valign="bottom">2</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Electrical</td><td align="left" valign="bottom">Acute Burn</td></tr><tr><td align="char" char="ndash" valign="bottom">20–29</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Burn</td><td align="char" char="." valign="bottom">10</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Flame</td><td align="left" valign="bottom">Acute Burn</td></tr><tr><td align="char" char="ndash" valign="bottom">40–49</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Burn</td><td align="char" char="." valign="bottom">13</td><td align="left" valign="bottom">7</td><td align="left" valign="bottom">Flash</td><td align="left" valign="bottom">Acute Burn</td></tr><tr><td align="char" char="ndash" valign="bottom">10–19</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Burn<xref ref-type="table-fn" rid="table1fn1">*</xref></td><td align="char" char="." valign="bottom">2</td><td align="left" valign="bottom">25</td><td align="left" valign="bottom">Flame</td><td align="left" valign="bottom">Late Phase Burn</td></tr><tr><td align="char" char="ndash" valign="bottom">50–59</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Burn</td><td align="char" char="." valign="bottom">14</td><td align="left" valign="bottom">5</td><td align="left" valign="bottom">Flame</td><td align="left" valign="bottom">Acute Burn</td></tr><tr><td align="char" char="ndash" valign="bottom">5–9</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Burn<xref ref-type="table-fn" rid="table1fn1">*</xref></td><td align="char" char="." valign="bottom">11</td><td align="left" valign="bottom">9</td><td align="left" valign="bottom">Scald</td><td align="left" valign="bottom">Late Phase Burn</td></tr><tr><td align="char" char="ndash" valign="bottom">40–49</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Burn<xref ref-type="table-fn" rid="table1fn1">*</xref></td><td align="char" char="." valign="bottom">26</td><td align="left" valign="bottom">7</td><td align="left" valign="bottom">Scald</td><td align="left" valign="bottom">Acute Burn</td></tr><tr><td align="char" char="ndash" valign="bottom">40–49</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Burn</td><td align="char" char="." valign="bottom">16</td><td align="left" valign="bottom">11</td><td align="left" valign="bottom">Flame</td><td align="left" valign="bottom">Late Phase Burn</td></tr><tr><td align="char" char="ndash" valign="bottom">30–39</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Burn</td><td align="char" char="." valign="bottom">1</td><td align="left" valign="bottom">27</td><td align="left" valign="bottom">Contact</td><td align="left" valign="bottom">Late Phase Burn</td></tr><tr><td align="char" char="ndash" valign="bottom">40–49</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Non-Burn</td><td align="char" char="." valign="bottom">9</td><td align="left" valign="bottom">9</td><td align="left" valign="bottom">Flame</td><td align="left" valign="bottom">Acute Non-Burn</td></tr><tr><td align="char" char="ndash" valign="bottom">30–39</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Non-Burn<xref ref-type="table-fn" rid="table1fn2"><sup>†</sup></xref></td><td align="char" char="." valign="bottom">10</td><td align="left" valign="bottom">n/a</td><td align="left" valign="bottom">Burn scar</td><td align="left" valign="bottom">Non-Burn</td></tr><tr><td align="char" char="ndash" valign="bottom">30–39</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Non-Burn</td><td align="char" char="." valign="bottom">0</td><td align="left" valign="bottom">n/a</td><td align="left" valign="bottom">Necrotizing fasciitis</td><td align="left" valign="bottom">Non-Burn</td></tr><tr><td align="char" char="ndash" valign="bottom">40–49</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Non-Burn<xref ref-type="table-fn" rid="table1fn1">*</xref></td><td align="char" char="." valign="bottom">0</td><td align="left" valign="bottom">n/a</td><td align="left" valign="bottom">Necrotizing fasciitis</td><td align="left" valign="bottom">Non-Burn</td></tr><tr><td align="char" char="ndash" valign="bottom">40–49</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Non-Burn<xref ref-type="table-fn" rid="table1fn1">*</xref></td><td align="char" char="." valign="bottom">26</td><td align="left" valign="bottom">14</td><td align="left" valign="bottom">Scald</td><td align="left" valign="bottom">Acute Non-Burn</td></tr><tr><td align="char" char="ndash" valign="bottom">30–39</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Non-Burn<xref ref-type="table-fn" rid="table1fn1">*</xref></td><td align="char" char="." valign="bottom">13</td><td align="left" valign="bottom">16</td><td align="left" valign="bottom">Electrical and flame</td><td align="left" valign="bottom">Acute Non-Burn</td></tr><tr><td align="char" char="ndash" valign="bottom">40–39</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Non-Burn</td><td align="char" char="." valign="bottom">49</td><td align="left" valign="bottom">9</td><td align="left" valign="bottom">Flame</td><td align="left" valign="bottom">Acute Non-Burn</td></tr><tr><td align="char" char="ndash" valign="bottom">60–69</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Non-Burn</td><td align="char" char="." valign="bottom">2</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Electrical</td><td align="left" valign="bottom">Acute Non-Burn</td></tr></tbody></table><table-wrap-foot><fn id="table1fn1"><label>*</label><p>Denotes sample was used for scRNA-seq. Acute non-burn = autograft tissue from acute burn patients.</p></fn><fn id="table1fn2"><label>†</label><p>Denotes sample was used for data analysis in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplements 1</xref> and <xref ref-type="fig" rid="fig1s2">2</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref> only.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-2"><title>Conventional CD4+ and CD8+ T cells in burn tissue show lower CD69 expression and produce more IFN-γ upon stimulation compared to T cells from non-burn tissue</title><p>Focusing on conventional T cells using flow cytometry, we found that burn tissue CD4+ T cells showed significantly lower expression of the T cell residency marker CD69 (p=0.0002) (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>, <xref ref-type="bibr" rid="bib37">Mackay et al., 2013</xref>; <xref ref-type="bibr" rid="bib17">Gebhardt et al., 2009</xref>; <xref ref-type="bibr" rid="bib30">Kumar et al., 2017</xref>) and significantly higher expression of CD38, a marker of chronic activation (p=0.002) compared to non-burn CD4 +T cells (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>; <xref ref-type="bibr" rid="bib56">Song et al., 2020</xref>). We then looked at the expression of specific intracellular cytokines suggested by prior studies to be important in burn tissue immune environment (<xref ref-type="bibr" rid="bib6">Blears et al., 2020</xref>). After treatment for 2 hr with PMA-ionomycin, we saw significantly higher expression of IFN-γ (p=0.0019) and TNF-α (p=0.0068) in CD4+ T cells in burn tissue compared to non-burn tissue (<xref ref-type="fig" rid="fig2">Figure 2C–E</xref>). Lastly, we saw significantly higher proportion of IL-10+CD4+ T cells in unstimulated burn tissue compared to unstimulated non-burn tissue (p=0.017, <xref ref-type="fig" rid="fig2">Figure 2F</xref>). We had similar findings in CD8+ T cells, where CD69 expression was significantly lower (p&lt;0.0001) and CD38 significantly higher (p=0.015) in burn tissue and compared to non-burn tissue (<xref ref-type="fig" rid="fig2">Figure 2G and H</xref>), and upon stimulation, we saw in burn tissue higher expression of IFN-γ (p=0.0003) and TNF-α (p=0.0002) (<xref ref-type="fig" rid="fig2">Figure 2J–L</xref>) compared to non-burn tissue. We did not see any differences in IL-10 production or pro-inflammatory cytokine production in unstimulated conditions in CD8+ T cells from burn tissue (<xref ref-type="fig" rid="fig2">Figure 2I–L</xref>). When comparing ‘acute burn’ and ‘acute non-burn’ we saw similar differences in CD69 expression and pro-inflammatory cytokine output in CD4 +and CD8+T cells following stimulation (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Taken together, we found that conventional CD4+ and CD8+ T cells from burn tissue have lower CD69 expression and produce higher pro-inflammatory cytokines IFN-γ and TNF-α upon stimulation compared to non-burn tissue.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Conventional CD4 +and CD8+T cells in burn tissue produce more pro-inflammatory cytokines upon stimulation compared to those from non-burn tissue.</title><p>Representative gating of CD69 and CD38 of CD4+ T cells and frequency of CD69+ and CD38+ CD4+ T cells in burn and non-burn tissue (<bold>A,B</bold>). Representative gating of IFN-γ+and TNF-α+ CD4+ T cells in unstimulated conditions and after 2 hr PMA-ionomycin stimulation in burn tissue and non-burn tissue (<bold>C</bold>). Quantification of frequency of IFN-γ+, TNF-α+, and IL-10+ CD4+T cells between burn and non-burn tissue in unstimulated conditions and after 2 hr PMA-ionomycin stimulation (<bold>D–F</bold>). Representative gating of CD69 and CD38 of CD8+ T cells and frequency of CD69+ and CD38+ CD8+T cells in burn and non-burn tissue (<bold>G,H</bold>). Representative gating of IFN-γ+ and TNF-α+ CD8+T cells in unstimulated conditions and after 2 hr PMA-ionomycin stimulation in burn tissue and non-burn tissue (<bold>J</bold>). Quantification of frequency of IFN-γ+, TNF-α+, and IL-10+ CD8+T cells between burn and non-burn tissue in unstimulated conditions and after 2 hr PMA-ionomycin stimulation (<bold>I, K, L</bold>). Error bars shown are of median with interquartile range. Differences between burn and non-burn were calculated using Mann-Whitney <italic>U</italic> test with *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82626-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Conventional CD4 +and CD8+T cells in acute burn tissue and late phase burn tissue produce more pro-inflammatory cytokines upon stimulation compared to those from acute non-burn tissue.</title><p>Frequency of CD69 +and CD38+CD4+T cells in burn and non-burn tissue (<bold>A</bold>). Quantification of frequency of IFN-γ+, TNF-α+, and IL-10 +CD4+T cells between burn and non-burn tissue in unstimulated conditions and after 2 hr PMA-ionomycin stimulation (<bold>B–D</bold>). Frequency of CD69 +and CD38+CD8+T cells in burn and non-burn tissue (<bold>E</bold>). Quantification of frequency of IFN-γ+, TNF-α+, and IL-10 +CD8+T cells between burn and non-burn tissue in unstimulated conditions and after 2 hr PMA-ionomycin stimulation (<bold>F–H</bold>). Error bars shown are of median with interquartile range. Differences between groups were calculated using Mann-Whitney <italic>U</italic> test with *p&lt;0.05, **p&lt;0.01.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82626-fig2-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Unconventional T cells in burn tissue have lower CD69 expression and produce more IFN-γ and TNF-α upon stimulation compared to non-burn tissue</title><p>We then examined unconventional T cells, including γ<italic>δ</italic> T cells and MAIT cells using flow cytometry. As seen in conventional T cells, CD69 expression in MAIT cells was significantly lower (p=0.0002) in burn tissue than non-burn tissue (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). Burn tissue MAIT cells had significantly higher CD38 expression compared to non-burn tissue (p=0.01) (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). With 2 hr PMA-Ionomycin stimulation, we saw a significantly higher expression of IFN-γ (p=0.0002) and TNF-α (p=0.003) in burn tissue MAIT cells compared to non-burn tissue MAIT cells (<xref ref-type="fig" rid="fig3">Figure 3C–E</xref>), but no differences were seen in IL-10 and IL-17A between these tissues (<xref ref-type="fig" rid="fig3">Figure 3F and G</xref>), nor in any examined cytokines in unstimulated conditions. In γδ T cells, there was significantly lower CD69 expression in burn tissue compared to non-burn tissue (p=0.006), although CD38 expression was not significantly different (<xref ref-type="fig" rid="fig3">Figure 3H1</xref>). Following PMA-Ionomycin stimulation, we saw significantly higher IFN-γ (p=0.01) and TNF-α (p=0.007) production in burn tissue γδ T cells compared to non-burn tissue (<xref ref-type="fig" rid="fig3">Figure 3K and L</xref>). In unstimulated conditions, significantly higher TNF-α (p=0.015) in burn tissue γδ T cells was noted compared to non-burn tissue, while there were no other significant differences in cytokine production (<xref ref-type="fig" rid="fig3">Figure 3J–M</xref>). When comparing ‘acute burn’ and ‘acute non-burn’ we saw similar differences in CD69 expression and IFN-γ and TNF-α output following stimulation in MAIT cells and γδ T cells (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Overall, like conventional CD4+ and CD8+ T cells, MAIT cells and γδ T cells in burn tissue have a higher capacity to express the pro-inflammatory cytokines IFN-γ and TNF-α upon stimulation.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Unconventional T cells in burn tissue produce more IFN-γ and TNF-α upon stimulation compared to non-burn tissue.</title><p>Representative gating of CD69+ and CD38+ MAIT cells in burn tissue and non-burn tissue (<bold>A</bold>) Frequency of CD69 +and CD38+ MAIT cells in burn tissue and non-burn tissue (<bold>B</bold>). Representative gating of IFN-γ+ and TNF-α+ of unstimulated MAIT cells and stimulated MAIT cells following 2 hr PMA-ionomycin stimulation in burn tissue and non-burn tissue (<bold>C</bold>). Frequency of IFN-γ+, TNF-α+, IL-10+, and IL-17A+ in unstimulated and stimulated MAIT cells after 2 hr PMA-ionomycin in burn tissue and non-burn tissue (<bold>E–G</bold>). Representative gating of CD69+ and CD38+ γδ T cells and quantification of frequency of CD69+ and CD38+ γδ T cells in burn tissue and non-burn tissue (<bold>H,I</bold>). Frequency of IL-17A+ in unstimulated and stimulated γδ T cells after 2 hr PMA-ionomycin in burn tissue and non-burn tissue (<bold>J</bold>). Representative gating of IFN-γ+ and TNF-α+ of unstimulated γδ T cells and stimulated γδ T cells and quantification of frequency of IFN-γ+ and TNF-α+ γδ T cells in burn tissue and non-burn tissue (<bold>K–M</bold>). Error bars shown are of median with interquartile range. Differences between burn and non-burn were calculated using Mann-Whitney <italic>U</italic> test with *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82626-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Unconventional T cells in burn acute tissue produce more IFN-γ and TNF-α upon stimulation compared to acute non-burn tissue.</title><p>Frequency of CD69+ and CD38+M AIT cells in burn tissue and non-burn tissue (<bold>A</bold>). Frequency of IFN-γ+, TNF-α+, IL-10+, and IL-17A+ in unstimulated and stimulated MAIT cells after 2 hr PMA-ionomycin in burn tissue and non-burn tissue (<bold>B–E</bold>). Quantification of frequency of CD69+ and CD38+ γδ T cells in burn tissue and non-burn tissue (<bold>F</bold>). Frequency of IL-17A+, IFN-γ+, and TNF-α+in unstimulated and stimulated γδ T cells after 2 hr PMA-ionomycin in burn tissue and non-burn tissue (<bold>G–I</bold>).Error bars shown are of median with interquartile range. Differences between groups were calculated using Mann-Whitney <italic>U</italic> test with*p&lt;0.05, **p&lt;0.01, ***p&lt;0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82626-fig3-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-4"><title>Conventional T cells in burn tissue are transcriptionally distinct from those in non-burn tissue</title><p>To get a broader view of the effects of burn trauma on human skin CD3 +T cells, we performed targeted single-cell RNA-sequencing (scRNA-seq), using the BD Rhapsody platform, on three burn tissues and three non-burn tissue samples (<xref ref-type="table" rid="table1">Table 1</xref>). Dimensional reduction and visualization using Uniform Manifold Approximation and Projection (UMAP) demonstrated that non-burn and burn T cells cluster separately in fifteen different populations (<xref ref-type="fig" rid="fig4">Figure 4A and B</xref>). The differentially expressed genes in the largest cluster, cluster 0, which primarily consisted of non-burn T cells, include <italic>IL7R</italic> (log2 fold change comparing burn to non-burn tissue L<sub>2</sub>FC = 1.1, p.adj &lt;9e-330), <italic>LGALS1</italic> (L<sub>2</sub>FC = 1.1, p.adj=2.8e-320) and <italic>CD69</italic> (L<sub>2</sub>FC = 1.3, p.adj=6.6e-269) (<xref ref-type="fig" rid="fig4">Figure 4C and D</xref>). Cluster 1, a large population consisting mostly of burn tissue, had significantly higher expression of genes encoding for homing receptors compared to non-burn T cells, including <italic>SELL</italic> (L<sub>2</sub>FC = 2.8, p.adj &lt;9e-330) and <italic>S1PR1</italic> (L<sub>2</sub>FC = 2.9, p.adj &lt;9e-330) (<xref ref-type="fig" rid="fig4">Figure 4C and D</xref>). When we look at the top 8 genes differentiating burn from non-burn samples, we saw that T cells in burn tissue have higher expression of <italic>SELL</italic>, <italic>CCR7</italic> and <italic>S1PR1</italic> and have lower <italic>CD69</italic> expression compared to non-burn samples (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). When comparing protein expression using antibody-oligonucleotide conjugates (AbSeq), we found lower protein expression of PD-1 and CD25 in the burn tissue T cells compared to non-burn (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). We confirmed our previous findings from flow cytometry, finding a lower proportion of CD8+ T cells (39% vs 63% CD8A expression, p.adj=5.4e-103) in burn tissue (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). We also confirmed the differences in gene expression of <italic>ITGAE</italic> (encoding CD103) and <italic>CD69</italic> by flow cytometry, finding that there are significantly lower frequencies of CD103+CD69+CD3+ T cells in burn tissue compared to non-burn tissue (<xref ref-type="fig" rid="fig4">Figure 4H</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Conventional T cells in burn tissue are transcriptionally distinct from those in non-burn tissue.</title><p>UMAP analysis using resolution = 0.8 in Seurat of 15 different clusters of T cells (<bold>A</bold>). Identification of burn and non-burn tissue T cells using Sample Tag calling from BD Rhapsody workflow (<bold>B</bold>). The key genes found that discriminate the 15 clusters (<bold>C</bold>). Heatmap of the top 5 differentially expressed genes using MAST that identify clusters associated with T cells in burn or non-burn tissue (<bold>D</bold>). Heatmap of the top 8 differentially expressed genes between the three burn and three non-burn samples (<bold>E</bold>). Violin plot of AbSeq expression of receptors between burn and non-burn CD3+ T cells (<bold>F</bold>). Sunplot of the proportion of T cell subsets of CD4+, CD8+, MAIT (TRAV1-2+and CD161+), and γδ T cells (TRDC +TRGC+) between burn and non-burn tissues, definitions of CD4+ and CD8+ subsets were taken from <xref ref-type="bibr" rid="bib38">Mair et al., 2020</xref> (<bold>G</bold>). Flow cytometry showing gating strategy and frequency of CD69+CD103+ of CD3+T cells in burn and non-burn tissue (<bold>H</bold>). Error bars shown are of median with interquartile range. Differences between burn and non-burn were calculated using Mann-Whitney <italic>U</italic> test with *p&lt;0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82626-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Differential expression of cytokines and effector molecules of conventional CD3 +T cells in burn and non-burn tissues.</title><p>Volcano plot of differentially expressed genes between burn and non-burn CD3+ T cells with cytokines and effector molecules labeled (<bold>A</bold>). Violin plots of selected genes from burn and non-burn CD3+ T cells and significantly differentially expressed genes from volcano plot (<bold>B–C</bold>). Gene ontology pathway analysis of GO Biological Processes 2021 using R package enrichR showing the positively and negatively enriched pathways associated with burn tissue CD3+ T cells compared to non-burn tissue CD3+ T cells (<bold>D</bold>). KEGG 2021 Human pathway analysis using R package enrichR showing the positively and negatively enriched pathways associated with burn tissue CD3+ T cells compared to non-burn tissue CD3+ T cells (<bold>E</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82626-fig4-figsupp1-v1.tif"/></fig></fig-group><p>Lastly, we see that expression of effector molecules <italic>IFNG</italic>, <italic>TNF</italic>, <italic>NAMPT</italic>, <italic>GZMB</italic>, <italic>GZMH</italic>, and <italic>PRF1</italic> is lower in burn compared to non-burn CD3+ T cells (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A-C</xref>). Gene ontology (GO) analysis shows that T cell activation and positive regulation of cytokine production are positively associated with burn T cells while apoptotic processes are negatively associated with burn T cells. (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>). Lastly, KEGG analysis of CD3+ T cells shows Th17, Th1, and Th2 cell differentiation are positively associated with burn T cells while cytokine-cytokine receptor interactions and T cell receptor signaling pathways are negatively associated with burn T cells (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E</xref>).</p><p>On closer examination of conventional T cell subsets, we found that CD4+ T cells from burn and non-burn tissue comprised of 11 clusters and had distinctly separate clustering based on UMAP analysis (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>). Cluster 0, which consisted mostly of non-burn CD4+ T cells, has high expression of <italic>IL7R</italic>, <italic>CD69</italic>, and <italic>LGALS1</italic> suggesting a tissue residency signature (<xref ref-type="fig" rid="fig5">Figure 5A–C</xref>). Meanwhile, cluster 1, primarily burn CD4+ T cells, expressed high <italic>S1PR1</italic>, <italic>CCR7</italic>, and <italic>SELL</italic> levels (<xref ref-type="fig" rid="fig5">Figure 5A–C</xref>). Cluster 2, situated in non-burn tissue, highly expressed <italic>FOXP3</italic> and <italic>CTLA4</italic>, suggesting an enriched T<sub>reg</sub> population (<xref ref-type="fig" rid="fig5">Figure 5A–C</xref>). When we look at the highly differentially expressed receptors in CD4+ cells, we see that <italic>S1PR1</italic>, <italic>CCR7</italic>, <italic>SELL</italic>, and <italic>ITGA4</italic> were exclusively expressed in burn tissue (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). Confirming our findings with flow cytometry, the AbSeq showed that CD4+ T cells in burn tissue express significantly lower CD69 and higher CD38, compared to non-burn tissue (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). A closer look at effector molecules shows that burn CD4+ T cells have lower expression of <italic>NAMPT</italic>, <italic>GZMA</italic>, <italic>PRF1</italic>, <italic>TNF</italic>, and <italic>CCL5</italic> compared to non-burn CD4+ T cells (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A, B</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>scRNA-seq reveals a conventional CD4+ and CD8+ T cell subset that trafficks to burn tissue.</title><p>Differentially expressed genes define the 10 clusters of CD4+ T cells within burn and non-burn tissue and separate based on tissue origin (<bold>A,B</bold>). Heatmap of the top 8 genes that significantly differentiate CD4+ T cells in burn and non-burn samples (<bold>C</bold>). Violin plot of highly significantly differentially expressed genes relating to tissue residency and homing between burn and non-burn CD4+ T cells (<bold>D</bold>). Violin plot of AbSeq protein expression of receptors between burn and non-burn CD4+ T cells (<bold>E</bold>). UMAP analysis define 10 clusters of CD8+ T cells that clustering separately based on tissue origin (<bold>F,G</bold>). Heatmap of the top 8 genes that significantly differentiate CD8+ T cells in burn and non-burn samples (<bold>H</bold>). Violin plot of T cell homing markers and residency markers of CD8+ T cells in burn and non-burn tissue (<bold>I</bold>). Violinplot of AbSeq protein expression of receptors between CD8+ T cells in burn and non-burn tissue (<bold>J</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82626-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Differential expression of cytokines and effector molecules of conventional CD4+ and CD8+ T cells in burn and non-burn tissues.</title><p>Volcano plot of differentially expressed genes between burn and non-burn CD4+ T cells with cytokines and effector molecules highlighted (<bold>A</bold>). Violin plots of selected genes from burn and non-burn CD4+ T cells and significantly differentially expressed genes from volcano plot (<bold>B</bold>). Volcano plot of differentially expressed genes between burn and non-burn CD8+ T cells with cytokines and effector molecules highlighted (<bold>C</bold>). Violin plots of selected genes from burn and non-burn CD8+ T cells and significantly differentially expressed genes from volcano plot (<bold>D</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82626-fig5-figsupp1-v1.tif"/></fig></fig-group><p>When we examined CD8+ T cells, we saw similar clustering as CD4+ T cells based on burn status (<xref ref-type="fig" rid="fig5">Figure 5F and G</xref>). The large cluster 0 situated in non-burn tissue show upregulation of several cytotoxic molecules, including <italic>GZMK</italic>, <italic>GZMH</italic>, and <italic>GNLY</italic> (<xref ref-type="fig" rid="fig5">Figure 5F–H</xref>). A similar cytotoxic CD8+ T cell cluster was seen in burn tissue found at cluster 4 (<xref ref-type="fig" rid="fig5">Figure 5F and H</xref>). We also saw that expression of <italic>NAMPT, TNF, IFNG, CCL4, and IL32</italic> were significantly lower in burn tissue CD8+ T cells compared to non-burn CD8+ T cells (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C, D</xref>). Similar to CD4+ T cells from the scRNA-seq data, we saw a burn tissue CD8+ population in clusters 3, 4, and 8, which highly expresses homing markers <italic>SELL</italic> and <italic>S1PR1</italic> (<xref ref-type="fig" rid="fig5">Figure 5H</xref>). Overall, we observed a significant higher expression of <italic>ITGA4</italic>, <italic>SELL</italic>, <italic>CCR7</italic>, <italic>SELPLG</italic>, and <italic>S1PR1</italic> and lower expression of <italic>CD69</italic> in burn tissue CD8+ T cells compared to non-burn tissue (<xref ref-type="fig" rid="fig5">Figure 5I</xref>). The AbSeq of CD8+ T cells shows a lower expression of PD1, CD25, and CD69 in CD8+ T cells in burn tissue and higher expression of CD38 in comparison to non-burn tissue (<xref ref-type="fig" rid="fig5">Figure 5K</xref>). A closer examination of effector molecules shows that burn CD8+ T cells have lower expression of <italic>NAMPT</italic>, <italic>GZMB</italic>, <italic>GZMH</italic>, <italic>TNF</italic>, and <italic>IL32</italic> and higher expression off <italic>CCL5 and GZMA</italic> compared to non-burn CD8+ T cells (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C, D</xref>).</p></sec><sec id="s2-5"><title>Unconventional T cells in burn tissue comprise a highly cytotoxic population not seen in non-burn tissue</title><p>Similar to our findings with conventional T cells, MAIT cells (defined in AbSeq as Vα7.2+and CD161+) from burn tissue clustered separately from those in non-burn tissue by UMAP analysis (<xref ref-type="fig" rid="fig6">Figure 6A and B</xref>). Cluster 0, positioned in burn tissue, showed highly upregulated cytotoxic genes, including <italic>PRF1</italic>, <italic>GZMK</italic>, and <italic>NKG7</italic> (<xref ref-type="fig" rid="fig6">Figure 6B and C</xref>). Cluster 1, positioned in non-burn tissue, exhibited upregulation of <italic>CD4</italic>, <italic>ICOS</italic>, and <italic>TIGIT</italic>, suggesting a MAIT T<sub>reg</sub> lineage; notably, we also identified <italic>FOXP3</italic>+ MAIT cells in this cluster (<xref ref-type="fig" rid="fig6">Figure 6B and D</xref>; <xref ref-type="bibr" rid="bib60">Vorkas et al., 2022</xref>). A further look into transcription factors associated with burn tissue MAIT cells showed a high proportion of <italic>RORC</italic>, while <italic>TBX21</italic> (encoding for T-bet) and <italic>ZBTB16</italic> (encoding for PLZF) had similar expression across tissues (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). As expected, burn tissue MAIT cells had lower expression of <italic>CD69</italic>, and higher expression of <italic>S1PR1</italic> and <italic>CCR7</italic>, like our findings in conventional T cell populations, compared to non-burn tissue (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). Notably, we also saw a significantly higher expression of <italic>CXCR6</italic> in burn tissue (<xref ref-type="fig" rid="fig6">Figure 6E</xref>), suggesting this may be a potential mechanism of MAIT cell trafficking. Taken together, burn tissue MAIT cells are highly cytotoxic and express markers for egress from tissue compared to non-burn MAIT cells.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Unconventional T cells in burn tissue comprise a highly cytotoxic population not seen in non-burn tissue.</title><p>UMAP analysis of MAIT cells (defined from AbSeq as Vα7.2+CD161+) within burn and non-burn tissue show three clusters of MAIT cells and their tissue origin (<bold>A,B</bold>). Heatmap of the three clusters of MAIT cells and the top 8 genes that are differentially expressed that define the clusters (<bold>C</bold>). Feature plot showing some commonly expressed MAIT cell transcription factors based on the UMAP in A. (<bold>D</bold>). Violin plot showing significantly differentially expressed T cell homing and residency genes between burn and non-burn MAIT cells (<bold>E</bold>). UMAP analysis of γδ T cells (Defined as TRDC+TRGC+ ) reveals 5 separate clusters within burn and non-burn tissue which are distinct based on tissue origin (<bold>F,G</bold>). Heatmap showing the top 5 genes identifying each cluster in F (<bold>H</bold>). Violin plots of significantly differentially expressed T cell homing and residency genes between burn and non-burn γδ T cells (<bold>I</bold>). Violin plots of AbSeq protein expression between burn and non-burn γδ T cells (<bold>J</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82626-fig6-v1.tif"/></fig><p>We next looked at γδ T cells (defined as TRDC+and TRGC+), and we saw six distinct populations when analyzed using UMAP (<xref ref-type="fig" rid="fig6">Figure 6F and H</xref>). Cluster 0, mostly from burn tissue, exhibited high expression of cytotoxic molecules <italic>PRF1</italic> and <italic>GZMB</italic> (<xref ref-type="fig" rid="fig6">Figure 6H</xref>). Interestingly, cluster 0 also expressed a high level of <italic>KRLB1</italic> and <italic>IL18RAP</italic>, indicating a population of Vδ2 γδ T cells, known for being transcriptionally similar to MAIT cells (<xref ref-type="bibr" rid="bib45">Provine et al., 2018</xref>; <xref ref-type="bibr" rid="bib61">Wragg et al., 2020</xref>; <xref ref-type="bibr" rid="bib21">Gutierrez-Arcelus et al., 2019</xref>) Meanwhile, cluster 1, mainly from non-burn γδ T cells showed high expression of <italic>LGALS1</italic> (<xref ref-type="fig" rid="fig6">Figure 6F and H</xref>). Clusters 0 and 2 in burn tissue express <italic>SELL</italic>, <italic>CCR7</italic> and <italic>S1PR1</italic>, genes previously upregulated in burn tissue CD4+ and CD8+ T cells (<xref ref-type="fig" rid="fig6">Figure 6F and H</xref>). Burn tissue γδ T cells had higher expression of <italic>ITGAE</italic> and <italic>CXCR6</italic> compared to non-burn tissue. (<xref ref-type="fig" rid="fig6">Figure 6I</xref>). When comparing AbSeq profiles, burn tissue γδ T cells show lower expression of CD25, CD69, and PD1 while having comparable CD38 and CTLA4 expression to non-burn γδ T cells (<xref ref-type="fig" rid="fig6">Figure 6J</xref>). Burn tissue γδ T cells show higher expression of CD161 compared to non-burn tissue γδ T cells (<xref ref-type="fig" rid="fig6">Figure 6J</xref>). Overall, burn tissue γδ T cells displayed upregulation of cytotoxic and homing genes compared to non-burn tissue.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this report, we describe the phenotype and functionality of conventional T cells, MAIT cells, and γδ T cells in human non-burn skin and burn tissue using combination of flow cytometry and a targeted multi-omic analysis of protein and gene expression at the single-cell level. Despite studies reporting the effect of burn injury on circulating blood T cells (<xref ref-type="bibr" rid="bib41">Moins-Teisserenc et al., 2021</xref>; <xref ref-type="bibr" rid="bib24">Hur et al., 2015</xref>; <xref ref-type="bibr" rid="bib55">Sobouti et al., 2020</xref>), little is known about T cells in burn skin tissue. We found that following stimulation, conventional and unconventional T cells in burn tissue produce more pro-inflammatory cytokines TNF-α and IFN-γ compared to non-burn tissue. Additionally, we found altered transcriptional expression of homing receptors among T cells in burn tissue, suggesting the migration of T cells from circulation, possibly accounting for differences in cytokine production capacity.</p><p>Prior studies of cytokines in blood have found that IL-6, IL-10, and TNF-α increase in burn compared to healthy pediatric patients, that elevated circulating TNF-α is associated with death, (<xref ref-type="bibr" rid="bib55">Sobouti et al., 2020</xref>) and that decreased circulating TNF-α/IL-10 ratio is correlated with an increased chance of infection (<xref ref-type="bibr" rid="bib58">Tsurumi et al., 2016</xref>). In addition, the concentration of circulating TNF-α in human blood peak in the first day of burn injury while IFN-γ peaks in days 2–5 of burn injury (<xref ref-type="bibr" rid="bib4">Bergquist et al., 2019</xref>). Here, compared to non-burn tissue, we show that in burn tissue, a higher proportion of conventional T cells, γδ T cells, and MAIT cells produce TNF-α and IFN-γ upon stimulation. Based on studies showing the potential for TNF-α and IFN-γ to upregulate platelet-activating factor receptor on intestinal epithelial cells and promote wound closure (<xref ref-type="bibr" rid="bib5">Birkl et al., 2019</xref>), it is possible that the increased capacity of burn tissue T cells to produce TNF-α and IFN-γ may contribute to responses against secondary infection and support wound healing.</p><p>We found a significantly lower frequency of conventional CD8+ T cells in burn tissue, with CD4+ cells making up the bulk of the conventional T cell population. In contrast to mouse models of burn injury that show a significant increase in total T cells or decreases in γδ T cells following burn injury (<xref ref-type="bibr" rid="bib47">Rani et al., 2015</xref>; <xref ref-type="bibr" rid="bib48">Rani and Schwacha, 2017</xref>), we did not find differences in total T cells or unconventional T cells in burn tissue. While our extraction time for burn tissue and TBSA were similar to those conventionally used in mouse models (extraction at 3–7 days post-burn and 25% TBSA achieved through scalding) (<xref ref-type="bibr" rid="bib2">Alexander et al., 2002</xref>; <xref ref-type="bibr" rid="bib51">Schwacha and Somers, 1998</xref>), the type of burn injury studied may complicate comparison of inflammatory responses between human and mice (<xref ref-type="bibr" rid="bib26">Jeschke et al., 2020</xref>). Similarly, we saw a decrease in proportion of CD69+ conventional T cells in burn tissue compared to non-burn tissue, which others have reported in mice 3 days post burn (<xref ref-type="bibr" rid="bib47">Rani et al., 2015</xref>). In addition, our finding that both acute and late phase burn tissue had increased IFN-γ+ conventional T cells compared to acute non-burn tissue matches studies in mice, where there is an increased percentages of IFN-γ+ conventional T cells 7 days post-burn (<xref ref-type="bibr" rid="bib46">Rani et al., 2014</xref>). In total, our observations of conventional T cell phenotypes following burn injury in human skin tissue were similar to those reported in mice, but differences in trafficking of conventional T cells to the burn wound site between mice and humans remains to be determined.</p><p>Prior studies of tissue-resident CD4+ T cells in skin of healthy individuals show that they are predominantly CCR7-,( <xref ref-type="bibr" rid="bib8">Boniface et al., 2018</xref>), and more likely to be CD69+ and CCR7- compared with CD4+ T cells in the blood (<xref ref-type="bibr" rid="bib34">Li et al., 2016</xref>). Chronic inflammatory human skin conditions such as psoriasis show skin CD8+ and CD4+CD103+ T<sub>RM</sub> having no difference to CD103- T cells in IFN-γ production following PMA-ionomycin stimulation (<xref ref-type="bibr" rid="bib31">Kurihara et al., 2019</xref>). We found that in burn tissue, T cells are more likely to be CD69- compared to non-burn tissue, and our single-cell transcriptomics analysis identified a population of CD69CD4+ T cells in burn tissue, which express high levels of CCR7, SELL, S1PR1, receptors not known to be expressed on T<sub>RM</sub> cells (<xref ref-type="bibr" rid="bib50">Schenkel and Masopust, 2014</xref>; <xref ref-type="bibr" rid="bib30">Kumar et al., 2017</xref>). We hypothesize that following burn injury, there is a migration of peripheral blood CD69CCR7+CD4+ T cells to the burn site, though these cells are unlikely to contribute to the pro-inflammatory cytokine pool (<xref ref-type="bibr" rid="bib28">Klicznik, 2019</xref>). It is also possible that this lack of CD69 in skin-infiltrating T cells may cause decreased regulation of T cell inflammatory responses due to lower numbers of CD69<sup>+</sup> T<sub>reg</sub> cells (<xref ref-type="bibr" rid="bib20">Gorabi et al., 2020</xref>; <xref ref-type="bibr" rid="bib19">González-Amaro et al., 2013</xref>) Downregulation of CD69 in mice has shown to increase Th17 differentiation and subsequent increase pro-inflammatory cytokines. Consistent with this, we saw a positive association of Th17 differentiation in our KEGG pathway analysis with burn tissue expression of RORC, a transcription factor associated with Th17 cells (<xref ref-type="bibr" rid="bib19">González-Amaro et al., 2013</xref>; <xref ref-type="bibr" rid="bib39">Martín et al., 2010</xref>).</p><p>Recent studies have revealed that MAIT cells have the capacity for tissue repair, (<xref ref-type="bibr" rid="bib12">Constantinides et al., 2019</xref>; <xref ref-type="bibr" rid="bib33">Leng et al., 2019</xref>),associated with the expression of IL-17A and related pathways, and prior work in psoriatic skin lesions showed high IL-17A and IL-22 expression though comparison to healthy skin was lacking (<xref ref-type="bibr" rid="bib57">Teunissen et al., 2014</xref>). We did not see significant differences in IL-17A in skin MAIT cells after burn injury, (<xref ref-type="bibr" rid="bib12">Constantinides et al., 2019</xref>), with both non-burn and burn skin samples producing similar IL-17A following PMA-Ionomycin stimulation, at similar levels to that seen by others in psoriatic skin lesions (<xref ref-type="bibr" rid="bib57">Teunissen et al., 2014</xref>). The role of IL-17A+ MAIT cells in tissue repair following burn injury remains unclear. On the other hand, we see a significantly higher percentage of IFN-γ+ and TNF-α+ MAIT cells following PMA-ionomycin treatment in burn tissue compared to non-burn tissue. This data, paired with the large population of MAIT cells expressing cytotoxicity related genes in burn tissue, suggests that MAIT cells may act as a first responder to infection with potential to release cytolytic molecules to respond against infected or damaged cells.</p><p>Our study had several limitations. First, due to difficulty with obtaining burn tissue samples, this exploratory study had a low sample size. Thus, we were unable to stratify phenotypes based on sex and age, which are known to impact the frequency and functionality of MAIT cells in particular (<xref ref-type="bibr" rid="bib43">Novak et al., 2014</xref>; <xref ref-type="bibr" rid="bib35">Loh et al., 2020</xref>). Secondly, our use of a targeted approach for scRNA-seq limited the number of genes examined. One cytokine not present in our panel, IL-10, an anti-inflammatory cytokine shown by flow cytometry to have lower expression in burn tissue γδ T cells compared to non-burn tissue, could partly explain the higher pro-inflammatory cytokine production in burn tissue (<xref ref-type="bibr" rid="bib1">Akdis and Blaser, 2001</xref>; <xref ref-type="bibr" rid="bib54">Smith et al., 2018</xref>; <xref ref-type="bibr" rid="bib42">Ng et al., 2013</xref>). Third, our skin samples were collected from several different regions across the body, and skin from different regions may have intrinsic differences in chemokine and cytokine expression (<xref ref-type="bibr" rid="bib3">Béke et al., 2018</xref>). Lastly, the difference in thickness of the dermis layer between burn tissue samples and some non-burn tissue samples could lead to variations in T cell frequency, receptor expression, and cytokine expression, especially in CD69+CD103+ T<sub>RM</sub> cells (<xref ref-type="bibr" rid="bib23">Ho and Kupper, 2019</xref>; <xref ref-type="bibr" rid="bib29">Kortekaas Krohn et al., 2022</xref>).</p><p>In conclusion, we used flow cytometry, scRNA-seq, and AbSeq methods to show that conventional and unconventional T cell populations in burn skin and non-burn skin are significantly different. T cells in burn skin show higher pro-inflammatory cytokine potential, and the unconventional T cells in burn skin show higher cytotoxic gene expression than non-burn counterparts. Our transcriptomic analysis revealed many differentially expressed genes between burn and non-burn tissue, which could provide information to further investigations on the immune mechanism behind burn injury and wound healing. Overall, the landscape of T cells in burn injury compared to non-burn skin suggests that T cells are shifted towards a pro-inflammatory rather than a homeostatic tissue-resident phenotype. Further investigation of the role that T cells play in tissue repair following burn injury is needed.</p></sec><sec id="s4" sec-type="methods"><title>Methods</title><sec id="s4-1"><title>Human subjects and enzymatic processing of skin tissue</title><p>Samples of discarded non-burn (7 donors) and burn tissue (11 donors) were obtained from through the University of Utah Burn Center, under a protocol (IRB#150686) reviewed by the University of Utah IRB and determined to be non-human subjects research. Discarded tissue was placed into RPMI-1640 media immediately after removal in the surgical suite and brought to laboratory for immediate processing. The skin was washed 1 x with RPMI-1640 and then stamped 16 times with a 3 mm biopsy punch. Four 3 mm pieces were placed in a gentleMACS C tube (Miltenyi Biotech) with 500 µL of RPMI-1640. For a 2 hr digestion, the Tumor Dissociation Kit was used (Miltenyi Biotech) with 100 µL of enzyme M, 25 µL of enzyme R, and 12.5 µL of enzyme A was added to each tube. After digestion 500 µL of cold RPMI-1640 was added and the tubes were placed on a gentleMACS dissociator (Miltenyi Biotech) and set to the h_skin_01 program at room temperature to shear the samples. The tubes were briefly spun down to get any remaining samples and washed with RPMI-1640 twice through a 70 µM strainer. The cells were frozen at –80 °C for no more than 2 months.</p></sec><sec id="s4-2"><title>Flow cytometry</title><p>For phenotypic analysis of skin mononuclear cells, samples were thawed from –80 °C and treated with human Fc block (BD Biosciences, Cat#564220) for 20 minutes and were stained for surface markers: Zombie UV fixable viability dye (Biolegend, Cat#423107), anti-CD3-BUV395 (BD Biosciences, Cat# 563546), anti-CD8-PE-Cy5.5 (Molecular Probes, Cat#MHCD0818), anti-CD4-BUV496 (BD Biosciences, Cat# 612936), anti-Vα7.2-BV711 (Biolegend, Cat# 351731), anti-LAG3-BV785 (Biolegend, Cat# 369321), anti-CD69-BUV563 (BD Biosciences, Cat#748764), anti-TCRγδ-BV480 (BD Biosciences, Cat# 566076), anti-TCR Vα24-Jα18-APC-Fire 750 (Biolegend, Cat# 342927), anti-CTLA-4-PE-Cy5 (BD Biosciences, Cat#555854), anti-CD103-PE-Cy7 (Biolegend, Cat#350211), anti-CD25-BV650 (Biolegend, Cat# 02037), anti-PD-1-BV605 (Biolegend, Cat# 329923), anti-CD161-BV605 (Biolegend, Cat#339915), anti-TIM3-BV421 (Biolegend, Cat# 345007), anti-CD38-APC-Fire-810 (Biolegend, Cat# 303549), and anti-human MR1 5-OP-RU Tetramer (NIH Tetramer Core Facility). Skin mononuclear cells were stimulated with PMA-Ionomycin and extracellular transport blocked by brefeldin A for 3hr were stained for surface markers: anti-human MR1-5-OP-RU Tetramer (NIH Tetramer Core Facility), anti-CD3-BUV395 (BD Biosciences, Cat# 563546), anti-CD8-PE-Cy5.5 (Molecular Probes, Cat#MHCD0818), anti-CD4-BUV496 (BD Biosciences, Cat# 612936), anti-Vα7.2-BV711 (Biolegend, Cat# 351731), anti-TCRγδ-BV480 (BD Biosciences, Cat# 566076), anti-TCR Vα24-Jα18-APC-Fire 750 (Biolegend, Cat# 342927) and intracellularly stained for: anti-IL-17A-BV650 (BD Biosciences, Cat# 563746), anti-IL-10-PerCp-Cy5.5 (Biolegend, Cat# 501417), anti-IL-6-FITC (Biolegend, Cat# 501103), anti-IFN-γ-Alexa Fluor 700 (Biolegend, Cat#506515), anti-TNFα-ef450 (Invitrogen, Cat#48-7349-42). Sample data were acquired using a 5-laser Cytek Aurora flow cytometer (Cytek) and analyzed using FlowJo software v10 (Tree Star, Inc Ashland, OR).</p></sec><sec id="s4-3"><title>Targeted T cell single-cell mRNA sequencing and analysis</title><p>Three samples each of discarded non-burn and burn tissue were processed as previously stated. The skin mononuclear cells were treated with human Fc block (BD Biosciences, Cat#564220) for 20 minutes and were stained with eFlour 780 fixable viability dye (Invitrogen, Cat# 65-2860-40) and anti-CD3-Alexa Fluor 700 (Biolegend, Cat#300423) and CD3 +T cells were sorted on a 4-laser BD FACSAria 3. Cells were incubated with BD AbSeq Ab-oligo Vα7.2 and CD161 to identify MAIT cells within the CD3 +T cell populations. Single cells were isolated using Single Cell Capture system (BD Biosciences) and analyzed for live cells and amount of total single cells captured with the BD Rhapsody Single-cell Analysis System. Sequencing libraries of mRNA and cDNA of AbSeq were doing simultaneously using BD Rhapsody targeted mRNA and AbSeq amplification kits and protocol. The final libraries of the AbSeq and mRNA were analyzed using Agilent 2200 TapeStation. The AbSeq-oligos, Sample Multiplex Tags, and T cell mRNA targeted libraries were pooled together before sequencing on a NovaSeq6000 instrument (Illumina). For sequencing, 12,000 reads/cell were dedicated toward the targeted mRNA library, 10,000 reads/AbSeq-oligo, and 200 reads/Sample Tag. The FASTQ files were uploaded to Seven Bridges Genomics, and a workflow designed by BD Biosciences was used to analyze the data to demultiplex, identify cells based on AbSeq-oligo, and analyze the single-cell mRNA data. For specific instructions, refer to BD Single Cell Genomics Bioinformatics Handbook, Doc ID: 54169, Rev. 6.0 (<xref ref-type="bibr" rid="bib38">Mair et al., 2020</xref>). Analysis of the final count matrix was done with Seurat v4.0.3 in R v4.1.2. Using the Seurat object, gene ontology (database: GO_Molecular_Function_2021) and KEGG (database: KEGG_2021_Human) were performed through enrichR v3.1 package in R v4.1.2.</p></sec><sec id="s4-4"><title>Statistical analysis</title><p>For comparisons of non-burn tissue with burn tissue flow cytometric data, a Mann-Whitney <italic>U</italic> test was used. GraphPad Prism 8.3.0 software was used for statistical analysis of the flow cytometry data and p&lt;0.05 was considered statistically significant. For comparisons of scRNA-seq data between burn and non-burn, Seurat function FindMarkers with test MAST was used with min.pct=0.10 (<xref ref-type="bibr" rid="bib15">Finak et al., 2015</xref>). Volcano plots showing differentially expressed genes between burn and non-burn T cells were generated using EnhancedVolcano v1.12.0 package in R v4.1.2.</p></sec><sec id="s4-5"><title>Datasets Generated</title><p>scRNA-seq of sorted human CD3+ T cells from discarded burn and non-burn skin: Daniel Labuz and Daniel Leung, 2021, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/SRR23092707">https://www.ncbi.nlm.nih.gov/sra/SRR23092707</ext-link>, SRA, SRR23092707.</p><p>scRNA-seq of sorted human CD3+ T cells from discarded burn and non-burn skin: Daniel Labuz and Daniel Leung, 2021, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/SRR23092708">https://www.ncbi.nlm.nih.gov/sra/SRR23092708</ext-link>, SRA, SRR23092708.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Resources, Data curation, Supervision, Validation, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Resources</p></fn><fn fn-type="con" id="con4"><p>Resources</p></fn><fn fn-type="con" id="con5"><p>Resources, Data curation</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Resources, Validation, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Supervision, Funding acquisition, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The study protocol (IRB#150686) was reviewed by the University of Utah IRB and determined to be non-human subjects research.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-82626-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Files containing the analysis code is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/LeungLab/MAIT-Burn-Injury">https://github.com/LeungLab/MAIT-Burn-Injury</ext-link> (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:fa69c45c057ce8cd16c33b704fd4b6ab1b6c2d14;origin=https://github.com/LeungLab/MAIT-Burn-Injury;visit=swh:1:snp:1b4d2356705bfd07c055c2daa0068a98a752a8fe;anchor=swh:1:rev:55d8c79ead016cff2a8fef97e94c381ae82f5f34">swh:1:rev:55d8c79ead016cff2a8fef97e94c381ae82f5f34</ext-link> ). The scRNA sequencing files have been uploaded to NCBI BioProject <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA924066">PRJNA924066</ext-link> (NCBI SRA. ID: SRR23092708 and SRR23092707).</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Labuz</surname><given-names>D</given-names></name><name><surname>Leung</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>scRNA-seq of sorted human CD3+ T cells from discarded burn and non-burn skin</data-title><source>NCBI SRA</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/sra/SRR23092707">SRR23092707</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Labuz</surname><given-names>D</given-names></name><name><surname>Leung</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>scRNA-seq of sorted human CD3+ T cells from discarded burn and non-burn skin</data-title><source>NCBI SRA</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/sra/SRR23092708">SRR23092708</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This research was supported by the National Institutes of Health (R01AI130378 to DTL and TL1TR002540 to DL). We would like to thank all the study subjects who participated in the study. We would like to thank all the nurses and caregivers at the University of Utah burn center. We would also like to thank the staff of the University of Utah Flow Cytometry Core.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akdis</surname><given-names>CA</given-names></name><name><surname>Blaser</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Mechanisms of interleukin-10-mediated immune suppression</article-title><source>Immunology</source><volume>103</volume><fpage>131</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2567.2001.01235.x</pub-id><pub-id pub-id-type="pmid">11412299</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>M</given-names></name><name><surname>Chaudry</surname><given-names>IH</given-names></name><name><surname>Schwacha</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Relationships between burn size, immunosuppression, and macrophage hyperactivity in a murine model of thermal injury</article-title><source>Cellular Immunology</source><volume>220</volume><fpage>63</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1016/s0008-8749(03)00024-8</pub-id><pub-id pub-id-type="pmid">12718940</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Béke</surname><given-names>G</given-names></name><name><surname>Dajnoki</surname><given-names>Z</given-names></name><name><surname>Kapitány</surname><given-names>A</given-names></name><name><surname>Gáspár</surname><given-names>K</given-names></name><name><surname>Medgyesi</surname><given-names>B</given-names></name><name><surname>Póliska</surname><given-names>S</given-names></name><name><surname>Hendrik</surname><given-names>Z</given-names></name><name><surname>Péter</surname><given-names>Z</given-names></name><name><surname>Törőcsik</surname><given-names>D</given-names></name><name><surname>Bíró</surname><given-names>T</given-names></name><name><surname>Szegedi</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Immunotopographical differences of human skin</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>424</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.00424</pub-id><pub-id pub-id-type="pmid">29556238</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergquist</surname><given-names>M</given-names></name><name><surname>Hästbacka</surname><given-names>J</given-names></name><name><surname>Glaumann</surname><given-names>C</given-names></name><name><surname>Freden</surname><given-names>F</given-names></name><name><surname>Huss</surname><given-names>F</given-names></name><name><surname>Lipcsey</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The time-course of the inflammatory response to major burn injury and its relation to organ failure and outcome</article-title><source>Burns</source><volume>45</volume><fpage>354</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2018.09.001</pub-id><pub-id pub-id-type="pmid">30274808</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birkl</surname><given-names>D</given-names></name><name><surname>Quiros</surname><given-names>M</given-names></name><name><surname>García-Hernández</surname><given-names>V</given-names></name><name><surname>Zhou</surname><given-names>DW</given-names></name><name><surname>Brazil</surname><given-names>JC</given-names></name><name><surname>Hilgarth</surname><given-names>R</given-names></name><name><surname>Keeney</surname><given-names>J</given-names></name><name><surname>Yulis</surname><given-names>M</given-names></name><name><surname>Bruewer</surname><given-names>M</given-names></name><name><surname>García</surname><given-names>AJ</given-names></name><name><surname>O Leary</surname><given-names>MN</given-names></name><name><surname>Parkos</surname><given-names>CA</given-names></name><name><surname>Nusrat</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Tnfα promotes mucosal wound repair through enhanced platelet activating factor receptor signaling in the epithelium</article-title><source>Mucosal Immunology</source><volume>12</volume><fpage>909</fpage><lpage>918</lpage><pub-id pub-id-type="doi">10.1038/s41385-019-0150-8</pub-id><pub-id pub-id-type="pmid">30971752</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blears</surname><given-names>E</given-names></name><name><surname>Sommerhalder</surname><given-names>C</given-names></name><name><surname>Toliver-Kinsky</surname><given-names>T</given-names></name><name><surname>Finnerty</surname><given-names>CC</given-names></name><name><surname>Herndon</surname><given-names>DN</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Current problems in burn immunology</article-title><source>Current Problems in Surgery</source><volume>57</volume><elocation-id>100779</elocation-id><pub-id pub-id-type="doi">10.1016/j.cpsurg.2020.100779</pub-id><pub-id pub-id-type="pmid">32507131</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boldeanu</surname><given-names>L</given-names></name><name><surname>Boldeanu</surname><given-names>MV</given-names></name><name><surname>Bogdan</surname><given-names>M</given-names></name><name><surname>Meca</surname><given-names>AD</given-names></name><name><surname>Coman</surname><given-names>CG</given-names></name><name><surname>Buca</surname><given-names>BR</given-names></name><name><surname>Tartau</surname><given-names>CG</given-names></name><name><surname>Tartau</surname><given-names>LM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Immunological approaches and therapy in burns (review)</article-title><source>Experimental and Therapeutic Medicine</source><volume>20</volume><fpage>2361</fpage><lpage>2367</lpage><pub-id pub-id-type="doi">10.3892/etm.2020.8932</pub-id><pub-id pub-id-type="pmid">32765715</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boniface</surname><given-names>K</given-names></name><name><surname>Jacquemin</surname><given-names>C</given-names></name><name><surname>Darrigade</surname><given-names>AS</given-names></name><name><surname>Dessarthe</surname><given-names>B</given-names></name><name><surname>Martins</surname><given-names>C</given-names></name><name><surname>Boukhedouni</surname><given-names>N</given-names></name><name><surname>Vernisse</surname><given-names>C</given-names></name><name><surname>Grasseau</surname><given-names>A</given-names></name><name><surname>Thiolat</surname><given-names>D</given-names></name><name><surname>Rambert</surname><given-names>J</given-names></name><name><surname>Lucchese</surname><given-names>F</given-names></name><name><surname>Bertolotti</surname><given-names>A</given-names></name><name><surname>Ezzedine</surname><given-names>K</given-names></name><name><surname>Taieb</surname><given-names>A</given-names></name><name><surname>Seneschal</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Vitiligo skin is imprinted with resident memory CD8 T cells expressing CXCR3</article-title><source>The Journal of Investigative Dermatology</source><volume>138</volume><fpage>355</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1016/j.jid.2017.08.038</pub-id><pub-id pub-id-type="pmid">28927891</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>RA</given-names></name><name><surname>Chong</surname><given-names>B</given-names></name><name><surname>Mirchandani</surname><given-names>N</given-names></name><name><surname>Brinster</surname><given-names>NK</given-names></name><name><surname>Yamanaka</surname><given-names>KI</given-names></name><name><surname>Dowgiert</surname><given-names>RK</given-names></name><name><surname>Kupper</surname><given-names>TS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The vast majority of CLA+ T cells are resident in normal skin</article-title><source>Journal of Immunology</source><volume>176</volume><fpage>4431</fpage><lpage>4439</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.176.7.4431</pub-id><pub-id pub-id-type="pmid">16547281</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>RA</given-names></name><name><surname>Watanabe</surname><given-names>R</given-names></name><name><surname>Teague</surname><given-names>JE</given-names></name><name><surname>Schlapbach</surname><given-names>C</given-names></name><name><surname>Tawa</surname><given-names>MC</given-names></name><name><surname>Adams</surname><given-names>N</given-names></name><name><surname>Dorosario</surname><given-names>AA</given-names></name><name><surname>Chaney</surname><given-names>KS</given-names></name><name><surname>Cutler</surname><given-names>CS</given-names></name><name><surname>Leboeuf</surname><given-names>NR</given-names></name><name><surname>Carter</surname><given-names>JB</given-names></name><name><surname>Fisher</surname><given-names>DC</given-names></name><name><surname>Kupper</surname><given-names>TS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients</article-title><source>Science Translational Medicine</source><volume>4</volume><elocation-id>117ra7</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.3003008</pub-id><pub-id pub-id-type="pmid">22261031</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Resident memory T cells in human health and disease</article-title><source>Science Translational Medicine</source><volume>7</volume><elocation-id>269rv1</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.3010641</pub-id><pub-id pub-id-type="pmid">25568072</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Constantinides</surname><given-names>MG</given-names></name><name><surname>Link</surname><given-names>VM</given-names></name><name><surname>Tamoutounour</surname><given-names>S</given-names></name><name><surname>Wong</surname><given-names>AC</given-names></name><name><surname>Perez-Chaparro</surname><given-names>PJ</given-names></name><name><surname>Han</surname><given-names>SJ</given-names></name><name><surname>Chen</surname><given-names>YE</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Farhat</surname><given-names>S</given-names></name><name><surname>Weckel</surname><given-names>A</given-names></name><name><surname>Krishnamurthy</surname><given-names>SR</given-names></name><name><surname>Vujkovic-Cvijin</surname><given-names>I</given-names></name><name><surname>Linehan</surname><given-names>JL</given-names></name><name><surname>Bouladoux</surname><given-names>N</given-names></name><name><surname>Merrill</surname><given-names>ED</given-names></name><name><surname>Roy</surname><given-names>S</given-names></name><name><surname>Cua</surname><given-names>DJ</given-names></name><name><surname>Adams</surname><given-names>EJ</given-names></name><name><surname>Bhandoola</surname><given-names>A</given-names></name><name><surname>Scharschmidt</surname><given-names>TC</given-names></name><name><surname>Aubé</surname><given-names>J</given-names></name><name><surname>Fischbach</surname><given-names>MA</given-names></name><name><surname>Belkaid</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>MAIT cells are imprinted by the microbiota in early life and promote tissue repair</article-title><source>Science</source><volume>366</volume><elocation-id>aax6624</elocation-id><pub-id pub-id-type="doi">10.1126/science.aax6624</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daniel</surname><given-names>T</given-names></name><name><surname>Thobe</surname><given-names>BM</given-names></name><name><surname>Chaudry</surname><given-names>IH</given-names></name><name><surname>Choudhry</surname><given-names>MA</given-names></name><name><surname>Hubbard</surname><given-names>WJ</given-names></name><name><surname>Schwacha</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Regulation of the postburn wound inflammatory response by gammadelta T-cells</article-title><source>Shock</source><volume>28</volume><fpage>278</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1097/shk.0b013e318034264c</pub-id><pub-id pub-id-type="pmid">17545947</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebert</surname><given-names>LM</given-names></name><name><surname>Meuter</surname><given-names>S</given-names></name><name><surname>Moser</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Homing and function of human skin gammadelta T cells and NK cells: relevance for tumor surveillance</article-title><source>Journal of Immunology</source><volume>176</volume><fpage>4331</fpage><lpage>4336</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.176.7.4331</pub-id><pub-id pub-id-type="pmid">16547270</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finak</surname><given-names>G</given-names></name><name><surname>McDavid</surname><given-names>A</given-names></name><name><surname>Yajima</surname><given-names>M</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Gersuk</surname><given-names>V</given-names></name><name><surname>Shalek</surname><given-names>AK</given-names></name><name><surname>Slichter</surname><given-names>CK</given-names></name><name><surname>Miller</surname><given-names>HW</given-names></name><name><surname>McElrath</surname><given-names>MJ</given-names></name><name><surname>Prlic</surname><given-names>M</given-names></name><name><surname>Linsley</surname><given-names>PS</given-names></name><name><surname>Gottardo</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data</article-title><source>Genome Biology</source><volume>16</volume><elocation-id>278</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-015-0844-5</pub-id><pub-id pub-id-type="pmid">26653891</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finnerty</surname><given-names>CC</given-names></name><name><surname>Herndon</surname><given-names>DN</given-names></name><name><surname>Chinkes</surname><given-names>DL</given-names></name><name><surname>Jeschke</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Serum cytokine differences in severely burned children with and without sepsis</article-title><source>Shock</source><volume>27</volume><fpage>4</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1097/01.shk.0000235138.20775.36</pub-id><pub-id pub-id-type="pmid">17172973</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gebhardt</surname><given-names>T</given-names></name><name><surname>Wakim</surname><given-names>LM</given-names></name><name><surname>Eidsmo</surname><given-names>L</given-names></name><name><surname>Reading</surname><given-names>PC</given-names></name><name><surname>Heath</surname><given-names>WR</given-names></name><name><surname>Carbone</surname><given-names>FR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus</article-title><source>Nature Immunology</source><volume>10</volume><fpage>524</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1038/ni.1718</pub-id><pub-id pub-id-type="pmid">19305395</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbs</surname><given-names>A</given-names></name><name><surname>Leeansyah</surname><given-names>E</given-names></name><name><surname>Introini</surname><given-names>A</given-names></name><name><surname>Paquin-Proulx</surname><given-names>D</given-names></name><name><surname>Hasselrot</surname><given-names>K</given-names></name><name><surname>Andersson</surname><given-names>E</given-names></name><name><surname>Broliden</surname><given-names>K</given-names></name><name><surname>Sandberg</surname><given-names>JK</given-names></name><name><surname>Tjernlund</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>MAIT cells reside in the female genital mucosa and are biased towards IL-17 and IL-22 production in response to bacterial stimulation</article-title><source>Mucosal Immunology</source><volume>10</volume><fpage>35</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1038/mi.2016.30</pub-id><pub-id pub-id-type="pmid">27049062</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>González-Amaro</surname><given-names>R</given-names></name><name><surname>Cortés</surname><given-names>JR</given-names></name><name><surname>Sánchez-Madrid</surname><given-names>F</given-names></name><name><surname>Martín</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Is CD69 an effective brake to control inflammatory diseases?</article-title><source>Trends in Molecular Medicine</source><volume>19</volume><fpage>625</fpage><lpage>632</lpage><pub-id pub-id-type="doi">10.1016/j.molmed.2013.07.006</pub-id><pub-id pub-id-type="pmid">23954168</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorabi</surname><given-names>AM</given-names></name><name><surname>Hajighasemi</surname><given-names>S</given-names></name><name><surname>Kiaie</surname><given-names>N</given-names></name><name><surname>Gheibi Hayat</surname><given-names>SM</given-names></name><name><surname>Jamialahmadi</surname><given-names>T</given-names></name><name><surname>Johnston</surname><given-names>TP</given-names></name><name><surname>Sahebkar</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The pivotal role of CD69 in autoimmunity</article-title><source>Journal of Autoimmunity</source><volume>111</volume><elocation-id>102453</elocation-id><pub-id pub-id-type="doi">10.1016/j.jaut.2020.102453</pub-id><pub-id pub-id-type="pmid">32291138</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutierrez-Arcelus</surname><given-names>M</given-names></name><name><surname>Teslovich</surname><given-names>N</given-names></name><name><surname>Mola</surname><given-names>AR</given-names></name><name><surname>Polidoro</surname><given-names>RB</given-names></name><name><surname>Nathan</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Hannes</surname><given-names>S</given-names></name><name><surname>Slowikowski</surname><given-names>K</given-names></name><name><surname>Watts</surname><given-names>GFM</given-names></name><name><surname>Korsunsky</surname><given-names>I</given-names></name><name><surname>Brenner</surname><given-names>MB</given-names></name><name><surname>Raychaudhuri</surname><given-names>S</given-names></name><name><surname>Brennan</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Lymphocyte innateness defined by transcriptional states reflects a balance between proliferation and effector functions</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>687</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-08604-4</pub-id><pub-id pub-id-type="pmid">30737409</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinks</surname><given-names>TSC</given-names></name><name><surname>Marchi</surname><given-names>E</given-names></name><name><surname>Jabeen</surname><given-names>M</given-names></name><name><surname>Olshansky</surname><given-names>M</given-names></name><name><surname>Kurioka</surname><given-names>A</given-names></name><name><surname>Pediongco</surname><given-names>TJ</given-names></name><name><surname>Meehan</surname><given-names>BS</given-names></name><name><surname>Kostenko</surname><given-names>L</given-names></name><name><surname>Turner</surname><given-names>SJ</given-names></name><name><surname>Corbett</surname><given-names>AJ</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Klenerman</surname><given-names>P</given-names></name><name><surname>McCluskey</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Activation and in vivo evolution of the mait cell transcriptome in mice and humans reveals tissue repair functionality</article-title><source>Cell Reports</source><volume>28</volume><fpage>3249</fpage><lpage>3262</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.07.039</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>AW</given-names></name><name><surname>Kupper</surname><given-names>TS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>T cells and the skin: from protective immunity to inflammatory skin disorders</article-title><source>Nature Reviews. Immunology</source><volume>19</volume><fpage>490</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1038/s41577-019-0162-3</pub-id><pub-id pub-id-type="pmid">30992525</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hur</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>HT</given-names></name><name><surname>Chun</surname><given-names>W</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Shin</surname><given-names>SH</given-names></name><name><surname>Kang</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Inflammatory cytokines and their prognostic ability in cases of major burn injury</article-title><source>Annals of Laboratory Medicine</source><volume>35</volume><fpage>105</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.3343/alm.2015.35.1.105</pub-id><pub-id pub-id-type="pmid">25553289</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeschke</surname><given-names>MG</given-names></name><name><surname>Gauglitz</surname><given-names>GG</given-names></name><name><surname>Finnerty</surname><given-names>CC</given-names></name><name><surname>Kraft</surname><given-names>R</given-names></name><name><surname>Mlcak</surname><given-names>RP</given-names></name><name><surname>Herndon</surname><given-names>DN</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Survivors versus nonsurvivors postburn: differences in inflammatory and hypermetabolic trajectories</article-title><source>Annals of Surgery</source><volume>259</volume><fpage>814</fpage><lpage>823</lpage><pub-id pub-id-type="doi">10.1097/SLA.0b013e31828dfbf1</pub-id><pub-id pub-id-type="pmid">23579577</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeschke</surname><given-names>MG</given-names></name><name><surname>van Baar</surname><given-names>ME</given-names></name><name><surname>Choudhry</surname><given-names>MA</given-names></name><name><surname>Chung</surname><given-names>KK</given-names></name><name><surname>Gibran</surname><given-names>NS</given-names></name><name><surname>Logsetty</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Burn injury</article-title><source>Nature Reviews. Disease Primers</source><volume>6</volume><elocation-id>11</elocation-id><pub-id pub-id-type="doi">10.1038/s41572-020-0145-5</pub-id><pub-id pub-id-type="pmid">32054846</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kjer-Nielsen</surname><given-names>L</given-names></name><name><surname>Patel</surname><given-names>O</given-names></name><name><surname>Corbett</surname><given-names>AJ</given-names></name><name><surname>Le Nours</surname><given-names>J</given-names></name><name><surname>Meehan</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Bhati</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Kostenko</surname><given-names>L</given-names></name><name><surname>Reantragoon</surname><given-names>R</given-names></name><name><surname>Williamson</surname><given-names>NA</given-names></name><name><surname>Purcell</surname><given-names>AW</given-names></name><name><surname>Dudek</surname><given-names>NL</given-names></name><name><surname>McConville</surname><given-names>MJ</given-names></name><name><surname>O’Hair</surname><given-names>RAJ</given-names></name><name><surname>Khairallah</surname><given-names>GN</given-names></name><name><surname>Godfrey</surname><given-names>DI</given-names></name><name><surname>Fairlie</surname><given-names>DP</given-names></name><name><surname>Rossjohn</surname><given-names>J</given-names></name><name><surname>McCluskey</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mr1 presents microbial vitamin B metabolites to MAIT cells</article-title><source>Nature</source><volume>491</volume><fpage>717</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1038/nature11605</pub-id><pub-id pub-id-type="pmid">23051753</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klicznik</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy individuals</article-title><source>Science Immunology</source><volume>54</volume><elocation-id>eaav8995</elocation-id><pub-id pub-id-type="doi">10.1126/sciimmunol.aav8995</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kortekaas Krohn</surname><given-names>I</given-names></name><name><surname>Aerts</surname><given-names>JL</given-names></name><name><surname>Breckpot</surname><given-names>K</given-names></name><name><surname>Goyvaerts</surname><given-names>C</given-names></name><name><surname>Knol</surname><given-names>E</given-names></name><name><surname>Van Wijk</surname><given-names>F</given-names></name><name><surname>Gutermuth</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>T-Cell subsets in the skin and their role in inflammatory skin disorders</article-title><source>Allergy</source><volume>77</volume><fpage>827</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1111/all.15104</pub-id><pub-id pub-id-type="pmid">34559894</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>BV</given-names></name><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>Miron</surname><given-names>M</given-names></name><name><surname>Granot</surname><given-names>T</given-names></name><name><surname>Guyer</surname><given-names>RS</given-names></name><name><surname>Carpenter</surname><given-names>DJ</given-names></name><name><surname>Senda</surname><given-names>T</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Ho</surname><given-names>S-H</given-names></name><name><surname>Lerner</surname><given-names>H</given-names></name><name><surname>Friedman</surname><given-names>AL</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Farber</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Human tissue-resident memory T cells are defined by core transcriptional and functional signatures in lymphoid and mucosal sites</article-title><source>Cell Reports</source><volume>20</volume><fpage>2921</fpage><lpage>2934</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.08.078</pub-id><pub-id pub-id-type="pmid">28930685</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurihara</surname><given-names>K</given-names></name><name><surname>Fujiyama</surname><given-names>T</given-names></name><name><surname>Phadungsaksawasdi</surname><given-names>P</given-names></name><name><surname>Ito</surname><given-names>T</given-names></name><name><surname>Tokura</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Significance of IL-17A-producing CD8+CD103+ skin resident memory T cells in psoriasis lesion and their possible relationship to clinical course</article-title><source>Journal of Dermatological Science</source><volume>95</volume><fpage>21</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/j.jdermsci.2019.06.002</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamichhane</surname><given-names>R</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>de la Harpe</surname><given-names>SM</given-names></name><name><surname>Harrop</surname><given-names>TWR</given-names></name><name><surname>Hannaway</surname><given-names>RF</given-names></name><name><surname>Dearden</surname><given-names>PK</given-names></name><name><surname>Kirman</surname><given-names>JR</given-names></name><name><surname>Tyndall</surname><given-names>JDA</given-names></name><name><surname>Vernall</surname><given-names>AJ</given-names></name><name><surname>Ussher</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>TCR- or cytokine-activated CD8+ mucosal-associated invariant T cells are rapid polyfunctional effectors that can coordinate immune responses</article-title><source>Cell Reports</source><volume>28</volume><fpage>3061</fpage><lpage>3076</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.08.054</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leng</surname><given-names>T</given-names></name><name><surname>Akther</surname><given-names>HD</given-names></name><name><surname>Hackstein</surname><given-names>C-P</given-names></name><name><surname>Powell</surname><given-names>K</given-names></name><name><surname>King</surname><given-names>T</given-names></name><name><surname>Friedrich</surname><given-names>M</given-names></name><name><surname>Christoforidou</surname><given-names>Z</given-names></name><name><surname>McCuaig</surname><given-names>S</given-names></name><name><surname>Neyazi</surname><given-names>M</given-names></name><name><surname>Arancibia-Cárcamo</surname><given-names>CV</given-names></name><name><surname>Hagel</surname><given-names>J</given-names></name><name><surname>Powrie</surname><given-names>F</given-names></name><name><surname>Peres</surname><given-names>RS</given-names></name><name><surname>Millar</surname><given-names>V</given-names></name><name><surname>Ebner</surname><given-names>D</given-names></name><name><surname>Lamichhane</surname><given-names>R</given-names></name><name><surname>Ussher</surname><given-names>J</given-names></name><name><surname>Hinks</surname><given-names>TSC</given-names></name><name><surname>Marchi</surname><given-names>E</given-names></name><name><surname>Willberg</surname><given-names>C</given-names></name><name><surname>Klenerman</surname><given-names>P</given-names></name><collab>Oxford IBD Investigators</collab></person-group><year iso-8601-date="2019">2019</year><article-title>TCR and inflammatory signals tune human mait cells to exert specific tissue repair and effector functions</article-title><source>Cell Reports</source><volume>28</volume><fpage>3077</fpage><lpage>3091</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.08.050</pub-id><pub-id pub-id-type="pmid">31533032</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Olshansky</surname><given-names>M</given-names></name><name><surname>Carbone</surname><given-names>FR</given-names></name><name><surname>Ma</surname><given-names>JZ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Transcriptional analysis of T cells resident in human skin</article-title><source>PLOS ONE</source><volume>11</volume><elocation-id>e0148351</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0148351</pub-id><pub-id pub-id-type="pmid">26824609</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loh</surname><given-names>L</given-names></name><name><surname>Gherardin</surname><given-names>NA</given-names></name><name><surname>Sant</surname><given-names>S</given-names></name><name><surname>Grzelak</surname><given-names>L</given-names></name><name><surname>Crawford</surname><given-names>JC</given-names></name><name><surname>Bird</surname><given-names>NL</given-names></name><name><surname>Koay</surname><given-names>HF</given-names></name><name><surname>van de Sandt</surname><given-names>CE</given-names></name><name><surname>Moreira</surname><given-names>ML</given-names></name><name><surname>Lappas</surname><given-names>M</given-names></name><name><surname>Allen</surname><given-names>EK</given-names></name><name><surname>Crowe</surname><given-names>J</given-names></name><name><surname>Loudovaris</surname><given-names>T</given-names></name><name><surname>Flanagan</surname><given-names>KL</given-names></name><name><surname>Quinn</surname><given-names>KM</given-names></name><name><surname>Rossjohn</surname><given-names>J</given-names></name><name><surname>Thomas</surname><given-names>PG</given-names></name><name><surname>Eckle</surname><given-names>SBG</given-names></name><name><surname>McCluskey</surname><given-names>J</given-names></name><name><surname>Godfrey</surname><given-names>DI</given-names></name><name><surname>Kedzierska</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Human mucosal-associated invariant T cells in older individuals display expanded TCRαβ clonotypes with potent antimicrobial responses</article-title><source>Journal of Immunology</source><volume>204</volume><fpage>1119</fpage><lpage>1133</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1900774</pub-id><pub-id pub-id-type="pmid">31988181</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mace</surname><given-names>JE</given-names></name><name><surname>Park</surname><given-names>MS</given-names></name><name><surname>Mora</surname><given-names>AG</given-names></name><name><surname>Chung</surname><given-names>KK</given-names></name><name><surname>Martini</surname><given-names>W</given-names></name><name><surname>White</surname><given-names>CE</given-names></name><name><surname>Holcomb</surname><given-names>JB</given-names></name><name><surname>Merrill</surname><given-names>GA</given-names></name><name><surname>Dubick</surname><given-names>MA</given-names></name><name><surname>Wolf</surname><given-names>SE</given-names></name><name><surname>Wade</surname><given-names>CE</given-names></name><name><surname>Schwacha</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Differential expression of the immunoinflammatory response in trauma patients: burn vs. non-burn</article-title><source>Burns</source><volume>38</volume><fpage>599</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2011.10.013</pub-id><pub-id pub-id-type="pmid">22103986</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackay</surname><given-names>LK</given-names></name><name><surname>Rahimpour</surname><given-names>A</given-names></name><name><surname>Ma</surname><given-names>JZ</given-names></name><name><surname>Collins</surname><given-names>N</given-names></name><name><surname>Stock</surname><given-names>AT</given-names></name><name><surname>Hafon</surname><given-names>M-L</given-names></name><name><surname>Vega-Ramos</surname><given-names>J</given-names></name><name><surname>Lauzurica</surname><given-names>P</given-names></name><name><surname>Mueller</surname><given-names>SN</given-names></name><name><surname>Stefanovic</surname><given-names>T</given-names></name><name><surname>Tscharke</surname><given-names>DC</given-names></name><name><surname>Heath</surname><given-names>WR</given-names></name><name><surname>Inouye</surname><given-names>M</given-names></name><name><surname>Carbone</surname><given-names>FR</given-names></name><name><surname>Gebhardt</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The developmental pathway for CD103 (+) CD8+ tissue-resident memory T cells of skin</article-title><source>Nature Immunology</source><volume>14</volume><fpage>1294</fpage><lpage>1301</lpage><pub-id pub-id-type="doi">10.1038/ni.2744</pub-id><pub-id pub-id-type="pmid">24162776</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mair</surname><given-names>F</given-names></name><name><surname>Erickson</surname><given-names>JR</given-names></name><name><surname>Voillet</surname><given-names>V</given-names></name><name><surname>Simoni</surname><given-names>Y</given-names></name><name><surname>Bi</surname><given-names>T</given-names></name><name><surname>Tyznik</surname><given-names>AJ</given-names></name><name><surname>Martin</surname><given-names>J</given-names></name><name><surname>Gottardo</surname><given-names>R</given-names></name><name><surname>Newell</surname><given-names>EW</given-names></name><name><surname>Prlic</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A targeted multi-omic analysis approach measures protein expression and low-abundance transcripts on the single-cell level</article-title><source>Cell Reports</source><volume>31</volume><elocation-id>107499</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.03.063</pub-id><pub-id pub-id-type="pmid">32268080</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martín</surname><given-names>P</given-names></name><name><surname>Gómez</surname><given-names>M</given-names></name><name><surname>Lamana</surname><given-names>A</given-names></name><name><surname>Cruz-Adalia</surname><given-names>A</given-names></name><name><surname>Ramírez-Huesca</surname><given-names>M</given-names></name><name><surname>Ursa</surname><given-names>MA</given-names></name><name><surname>Yáñez-Mo</surname><given-names>M</given-names></name><name><surname>Sánchez-Madrid</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cd69 association with Jak3/Stat5 proteins regulates Th17 cell differentiation</article-title><source>Molecular and Cellular Biology</source><volume>30</volume><fpage>4877</fpage><lpage>4889</lpage><pub-id pub-id-type="doi">10.1128/MCB.00456-10</pub-id><pub-id pub-id-type="pmid">20696842</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mestas</surname><given-names>J</given-names></name><name><surname>Hughes</surname><given-names>CCW</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Of mice and not men: differences between mouse and human immunology</article-title><source>Journal of Immunology</source><volume>172</volume><fpage>2731</fpage><lpage>2738</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.172.5.2731</pub-id><pub-id pub-id-type="pmid">14978070</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moins-Teisserenc</surname><given-names>H</given-names></name><name><surname>Cordeiro</surname><given-names>DJ</given-names></name><name><surname>Audigier</surname><given-names>V</given-names></name><name><surname>Ressaire</surname><given-names>Q</given-names></name><name><surname>Benyamina</surname><given-names>M</given-names></name><name><surname>Lambert</surname><given-names>J</given-names></name><name><surname>Maki</surname><given-names>G</given-names></name><name><surname>Homyrda</surname><given-names>L</given-names></name><name><surname>Toubert</surname><given-names>A</given-names></name><name><surname>Legrand</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Severe altered immune status after burn injury is associated with bacterial infection and septic shock</article-title><source>Frontiers in Immunology</source><volume>12</volume><elocation-id>586195</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2021.586195</pub-id><pub-id pub-id-type="pmid">33737924</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>THS</given-names></name><name><surname>Britton</surname><given-names>GJ</given-names></name><name><surname>Hill</surname><given-names>EV</given-names></name><name><surname>Verhagen</surname><given-names>J</given-names></name><name><surname>Burton</surname><given-names>BR</given-names></name><name><surname>Wraith</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Regulation of adaptive immunity; the role of interleukin-10</article-title><source>Frontiers in Immunology</source><volume>4</volume><elocation-id>129</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2013.00129</pub-id><pub-id pub-id-type="pmid">23755052</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novak</surname><given-names>J</given-names></name><name><surname>Dobrovolny</surname><given-names>J</given-names></name><name><surname>Novakova</surname><given-names>L</given-names></name><name><surname>Kozak</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The decrease in number and change in phenotype of mucosal-associated invariant T cells in the elderly and differences in men and women of reproductive age</article-title><source>Scandinavian Journal of Immunology</source><volume>80</volume><fpage>271</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1111/sji.12193</pub-id><pub-id pub-id-type="pmid">24846411</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peck</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Epidemiology of burns throughout the world. Part I: distribution and risk factors</article-title><source>Burns</source><volume>37</volume><fpage>1087</fpage><lpage>1100</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2011.06.005</pub-id><pub-id pub-id-type="pmid">21802856</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Provine</surname><given-names>NM</given-names></name><name><surname>Binder</surname><given-names>B</given-names></name><name><surname>FitzPatrick</surname><given-names>MEB</given-names></name><name><surname>Schuch</surname><given-names>A</given-names></name><name><surname>Garner</surname><given-names>LC</given-names></name><name><surname>Williamson</surname><given-names>KD</given-names></name><name><surname>van Wilgenburg</surname><given-names>B</given-names></name><name><surname>Thimme</surname><given-names>R</given-names></name><name><surname>Klenerman</surname><given-names>P</given-names></name><name><surname>Hofmann</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Unique and common features of innate-like human Vδ2+ γδT cells and mucosal-associated invariant T cells</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>756</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.00756</pub-id><pub-id pub-id-type="pmid">29740432</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rani</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Schwacha</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Burn wound γδ T-cells support a Th2 and Th17 immune response</article-title><source>Journal of Burn Care &amp; Research</source><volume>35</volume><fpage>46</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1097/01.bcr.0000440705.91099.cc</pub-id><pub-id pub-id-type="pmid">24270084</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rani</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Scherer</surname><given-names>MR</given-names></name><name><surname>Cap</surname><given-names>AP</given-names></name><name><surname>Schwacha</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Activated skin γδ t-cells regulate t-cell infiltration of the wound site after burn</article-title><source>Innate Immunity</source><volume>21</volume><fpage>140</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1177/1753425913519350</pub-id><pub-id pub-id-type="pmid">24412847</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rani</surname><given-names>M</given-names></name><name><surname>Schwacha</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The composition of T-cell subsets are altered in the burn wound early after injury</article-title><source>PLOS ONE</source><volume>12</volume><elocation-id>e0179015</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0179015</pub-id><pub-id pub-id-type="pmid">28575063</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>JR</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Schwacha</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Burn induces a th-17 inflammatory response at the injury site</article-title><source>Burns</source><volume>37</volume><fpage>646</fpage><lpage>651</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2011.01.028</pub-id><pub-id pub-id-type="pmid">21353393</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schenkel</surname><given-names>JM</given-names></name><name><surname>Masopust</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Tissue-resident memory T cells</article-title><source>Immunity</source><volume>41</volume><fpage>886</fpage><lpage>897</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.12.007</pub-id><pub-id pub-id-type="pmid">25526304</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwacha</surname><given-names>MG</given-names></name><name><surname>Somers</surname><given-names>SD</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Thermal injury-induced immunosuppression in mice: the role of macrophage-derived reactive nitrogen intermediates</article-title><source>Journal of Leukocyte Biology</source><volume>63</volume><fpage>51</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1002/jlb.63.1.51</pub-id><pub-id pub-id-type="pmid">9469472</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwacha</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Gammadelta T-cells: potential regulators of the post-burn inflammatory response</article-title><source>Burns</source><volume>35</volume><fpage>318</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2008.08.002</pub-id><pub-id pub-id-type="pmid">18951718</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiow</surname><given-names>LR</given-names></name><name><surname>Rosen</surname><given-names>DB</given-names></name><name><surname>Brdicková</surname><given-names>N</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>An</surname><given-names>J</given-names></name><name><surname>Lanier</surname><given-names>LL</given-names></name><name><surname>Cyster</surname><given-names>JG</given-names></name><name><surname>Matloubian</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>CD69 acts downstream of interferon-alpha/beta to inhibit s1p1 and lymphocyte egress from lymphoid organs</article-title><source>Nature</source><volume>440</volume><fpage>540</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1038/nature04606</pub-id><pub-id pub-id-type="pmid">16525420</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>LK</given-names></name><name><surname>Boukhaled</surname><given-names>GM</given-names></name><name><surname>Condotta</surname><given-names>SA</given-names></name><name><surname>Mazouz</surname><given-names>S</given-names></name><name><surname>Guthmiller</surname><given-names>JJ</given-names></name><name><surname>Vijay</surname><given-names>R</given-names></name><name><surname>Butler</surname><given-names>NS</given-names></name><name><surname>Bruneau</surname><given-names>J</given-names></name><name><surname>Shoukry</surname><given-names>NH</given-names></name><name><surname>Krawczyk</surname><given-names>CM</given-names></name><name><surname>Richer</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Interleukin-10 directly inhibits CD8+ T cell function by enhancing N-glycan branching to decrease antigen sensitivity</article-title><source>Immunity</source><volume>48</volume><fpage>299</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2018.01.006</pub-id><pub-id pub-id-type="pmid">29396160</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobouti</surname><given-names>B</given-names></name><name><surname>Ghavami</surname><given-names>Y</given-names></name><name><surname>Asadifar</surname><given-names>B</given-names></name><name><surname>Jafarzadeh</surname><given-names>M</given-names></name><name><surname>Ghelman</surname><given-names>M</given-names></name><name><surname>Vaghardoost</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Determination of serum levels of interleukin-6, interleukin-8, interleukin-10, and tumor necrosis-alpha and their relationship with the total body surface area in children</article-title><source>Journal of Burn Care &amp; Research</source><volume>41</volume><fpage>539</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1093/jbcr/irz180</pub-id><pub-id pub-id-type="pmid">31701129</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>CB</given-names></name><name><surname>Zhang</surname><given-names>LL</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Fu</surname><given-names>YJ</given-names></name><name><surname>Jiang</surname><given-names>YJ</given-names></name><name><surname>Shang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>ZN</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>CD4+CD38+ central memory T cells contribute to HIV persistence in HIV-infected individuals on long-term art</article-title><source>Journal of Translational Medicine</source><volume>18</volume><elocation-id>02245-8</elocation-id><pub-id pub-id-type="doi">10.1186/s12967-020-02245-8</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teunissen</surname><given-names>MBM</given-names></name><name><surname>Yeremenko</surname><given-names>NG</given-names></name><name><surname>Baeten</surname><given-names>DLP</given-names></name><name><surname>Chielie</surname><given-names>S</given-names></name><name><surname>Spuls</surname><given-names>PI</given-names></name><name><surname>de Rie</surname><given-names>MA</given-names></name><name><surname>Lantz</surname><given-names>O</given-names></name><name><surname>Res</surname><given-names>PCM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The IL-17A-producing CD8+ T-cell population in psoriatic lesional skin comprises mucosa-associated invariant T cells and conventional T cells</article-title><source>The Journal of Investigative Dermatology</source><volume>134</volume><fpage>2898</fpage><lpage>2907</lpage><pub-id pub-id-type="doi">10.1038/jid.2014.261</pub-id><pub-id pub-id-type="pmid">24945094</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsurumi</surname><given-names>A</given-names></name><name><surname>Que</surname><given-names>YA</given-names></name><name><surname>Ryan</surname><given-names>CM</given-names></name><name><surname>Tompkins</surname><given-names>RG</given-names></name><name><surname>Rahme</surname><given-names>LG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>TNF-α/IL-10 ratio correlates with burn severity and may serve as a risk predictor of increased susceptibility to infections</article-title><source>Frontiers in Public Health</source><volume>4</volume><elocation-id>216</elocation-id><pub-id pub-id-type="doi">10.3389/fpubh.2016.00216</pub-id><pub-id pub-id-type="pmid">27761434</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Wilgenburg</surname><given-names>B</given-names></name><name><surname>Scherwitzl</surname><given-names>I</given-names></name><name><surname>Hutchinson</surname><given-names>EC</given-names></name><name><surname>Leng</surname><given-names>T</given-names></name><name><surname>Kurioka</surname><given-names>A</given-names></name><name><surname>Kulicke</surname><given-names>C</given-names></name><name><surname>de Lara</surname><given-names>C</given-names></name><name><surname>Cole</surname><given-names>S</given-names></name><name><surname>Vasanawathana</surname><given-names>S</given-names></name><name><surname>Limpitikul</surname><given-names>W</given-names></name><name><surname>Malasit</surname><given-names>P</given-names></name><name><surname>Young</surname><given-names>D</given-names></name><name><surname>Denney</surname><given-names>L</given-names></name><collab>STOP-HCV consortium</collab><name><surname>Moore</surname><given-names>MD</given-names></name><name><surname>Fabris</surname><given-names>P</given-names></name><name><surname>Giordani</surname><given-names>MT</given-names></name><name><surname>Oo</surname><given-names>YH</given-names></name><name><surname>Laidlaw</surname><given-names>SM</given-names></name><name><surname>Dustin</surname><given-names>LB</given-names></name><name><surname>Ho</surname><given-names>L-P</given-names></name><name><surname>Thompson</surname><given-names>FM</given-names></name><name><surname>Ramamurthy</surname><given-names>N</given-names></name><name><surname>Mongkolsapaya</surname><given-names>J</given-names></name><name><surname>Willberg</surname><given-names>CB</given-names></name><name><surname>Screaton</surname><given-names>GR</given-names></name><name><surname>Klenerman</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>MAIT cells are activated during human viral infections</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>11653</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms11653</pub-id><pub-id pub-id-type="pmid">27337592</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vorkas</surname><given-names>CK</given-names></name><name><surname>Krishna</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Aubé</surname><given-names>J</given-names></name><name><surname>Fitzgerald</surname><given-names>DW</given-names></name><name><surname>Mazutis</surname><given-names>L</given-names></name><name><surname>Leslie</surname><given-names>CS</given-names></name><name><surname>Glickman</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Single-cell transcriptional profiling reveals signatures of helper, effector, and regulatory MAIT cells during homeostasis and activation</article-title><source>Journal of Immunology</source><volume>208</volume><fpage>1042</fpage><lpage>1056</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.2100522</pub-id><pub-id pub-id-type="pmid">35149530</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wragg</surname><given-names>KM</given-names></name><name><surname>Tan</surname><given-names>HX</given-names></name><name><surname>Kristensen</surname><given-names>AB</given-names></name><name><surname>Nguyen-Robertson</surname><given-names>CV</given-names></name><name><surname>Kelleher</surname><given-names>AD</given-names></name><name><surname>Parsons</surname><given-names>MS</given-names></name><name><surname>Wheatley</surname><given-names>AK</given-names></name><name><surname>Berzins</surname><given-names>SP</given-names></name><name><surname>Pellicci</surname><given-names>DG</given-names></name><name><surname>Kent</surname><given-names>SJ</given-names></name><name><surname>Juno</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>High CD26 and low CD94 expression identifies an IL-23 responsive Vδ2+ T cell subset with a MAIT cell-like transcriptional profile</article-title><source>Cell Reports</source><volume>31</volume><elocation-id>107773</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.107773</pub-id><pub-id pub-id-type="pmid">32553157</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaid</surname><given-names>A</given-names></name><name><surname>Mackay</surname><given-names>LK</given-names></name><name><surname>Rahimpour</surname><given-names>A</given-names></name><name><surname>Braun</surname><given-names>A</given-names></name><name><surname>Veldhoen</surname><given-names>M</given-names></name><name><surname>Carbone</surname><given-names>FR</given-names></name><name><surname>Manton</surname><given-names>JH</given-names></name><name><surname>Heath</surname><given-names>WR</given-names></name><name><surname>Mueller</surname><given-names>SN</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Persistence of skin-resident memory T cells within an epidermal niche</article-title><source>PNAS</source><volume>111</volume><fpage>5307</fpage><lpage>5312</lpage><pub-id pub-id-type="doi">10.1073/pnas.1322292111</pub-id><pub-id pub-id-type="pmid">24706879</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.82626.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Brian S</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Icahn School of Medicine at Mount Sinai</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.08.30.505800" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.08.30.505800"/></front-stub><body><p>The work in analyzing the T cell repertoire by multi-omics analysis is very valuable for the field of wound biology and provides convincing data with regard to both conventional and conventional T cells and their putative contributions. This moves the field beyond examining classical mediators of wound healing such as macrophages and neutrophils. We look forward to seeing this important work in <italic>eLife</italic>.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.82626.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Kim</surname><given-names>Brian S</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Icahn School of Medicine at Mount Sinai</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>de Andrade</surname><given-names>Lucas F</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Icahn School of Medicine at Mount Sinai</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.08.30.505800">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.08.30.505800v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Targeted multi-omic analysis of human skin tissue identifies alterations of conventional and unconventional T cells associated with burn injury&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Mone Zaidi as the Senior Editor. The following individual involved in the review of your submission has agreed to reveal their identity: Lucas F. de Andrade (Reviewer #1).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) Can the authors give a more quantitative assessment of cytokine levels from the scRNA-seq datasets?</p><p>2) Please give both percentage and number of cells/mm3 for CD3+ and the subpopulations of T cells.</p><p>3) Can GSEA analyses be done to explain what pathways are actually enriched?</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>The authors should show the absolute numbers of each one of the T cell populations. That is done for total T cells, but I am asking about each one of them. The importance of that analysis is that when considering % a population decreases and another augments. Therefore it is hard to determine if there are more CD4 T cells or if their % just looks higher because there are fewer CD8 T cells, for example.</p><p>The authors could attempt to perform a gene set enrichment analysis with the sc RNA seq data to perhaps gain more information about additional functions of the T cell populations.</p><p>CD69 expression is highly different when comparing T cells from burned to non-burned skins. While we use it as a tissue residency marker, it also plays a function in lymphocytes. For example, CD69 appears to activate NK cells (PMID: 10447727). The authors could comment if the lack of CD69 alters the functions of skin-infiltrating T cells.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>The work is very interesting with the caveats below.</p><p>– Figure 1. The authors calculate both percentage and number of cells/mm3 for CD3+, while for the subpopulations only the percentage is presented. Because percentages can be misleading, authors should also present the numbers/mm3 for the other populations (even if only as Supplementary Material).</p><p>– The authors should include an example of the complete sequence of the gating strategy used in their flow cytometry (e.g. from FSCxSSC to the specific markers). This should be included in the Supplementary material.</p><p>– In the first part of the manuscript, there is an emphasis on the pro-inflammatory state of T cells in the burned skin tissue samples, which show enhanced production of cytokines like TNFa and IFNγ. This is not investigated or discussed, however, when the results from scRNA-seq are presented. What happens to the expression levels of these and other cytokines (e.g. chemokines)? While the heatmap shows cluster markers, it would be good to have the cytokine expression levels shown as well and whether these are down- or upregulated after burn injury. This could be done by creating volcano plots where each T cell subset is compared (normal vs burn tissue samples), with specific cytokines indicated as well as the threshold of significance (p-value). Authors should take advantage of their rich dataset to present information about any relevant cytokines there (including chemokines) and not be limited to the ones analyzed by flow cytometry.</p><p>– Although this is a descriptive work, the authors could explore more the meaning of their scRNA-seq data. A standard way to get an overall idea of which cellular processes and pathways are being stimulated or inhibited in large datasets like RNA-seq is the use of tools for pathway enrichment analysis. Therefore, authors should use their lists of genes affected by burn injury to perform a broader and unbiased analysis of how the function of these T cells is changing and how this may be related to processes like wound healing.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.82626.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Can the authors give a more quantitative assessment of cytokine levels from the scRNA-seq datasets?</p></disp-quote><p>We have added two supplemental figures showing the expression of cytokines by scRNA-seq in CD3+, CD8<sup>+</sup> and CD4<sup>+</sup> T cells. These are Figure 4-Supplement Figure 1 and Figure 5-Supplement Figure 1</p><p>Lines 212-214:</p><p>“Lastly, we see that expression of effector molecules IFNΓ, TNF, NAMPT, GZMB, GZMH, and PRF1 is lower in burn compared to non-burn CD3+ T cells (Figure 4-Supplement Figure 1A-C).”</p><p>Lines 233-236:</p><p>“A closer look at effector molecules shows that burn CD4<sup>+</sup> T cells have lower expression of <italic>NAMPT</italic>, <italic>GZMA</italic>, <italic>PRF1</italic>, <italic>TNF</italic>, and <italic>CCL5</italic> compared to non-burn CD4<sup>+</sup> T cells (Figure 5-Supplement Figure 1A-B).”</p><p>Lines 241-243:</p><p>“We also saw that expression of <italic>NAMPT, TNF, IFNΓ, CCL4, and IL32</italic> were significantly lower in burn tissue CD8<sup>+</sup> T cells compared to non-burn CD8<sup>+</sup> T cells (Figure 5-Supplement Figure 1C-D)</p><disp-quote content-type="editor-comment"><p>2) Please give both percentage and number of cells/mm3 for CD3+ and the subpopulations of T cells.</p></disp-quote><p>We have added a supplemental figure (Figure 1-Supplement Figure 2) that includes cell per mm<sup>3</sup> for CD4 and CD8 T cell populations.</p><p>Lines 125-127:</p><p>“We did not see any significant differences in absolute numbers of CD4<sup>+</sup> or CD8<sup>+</sup> T cells between burn and non-burn skin. (Figure 1-Supplement Figure 2B-C).”</p><disp-quote content-type="editor-comment"><p>3) Can GSEA analyses be done to explain what pathways are actually enriched?</p></disp-quote><p>We have added a supplemental figure that look at gene ontology (GO) and KEGG analyses for CD3 T cell scRNA-seq data, Figure 4-Supplement Figure 1.</p><p>Lines 214-221:</p><p>“Gene ontology (GO) analysis shows that T cell activation and positive regulation of cytokine production are associated with burn T cells while apoptotic processes are negatively associated with burn T cells. (Figure 4-Supplement Figure 1D). Lastly, KEGG analysis of CD3+ T cells shows Th17, Th1, and Th2 cell differentiation are highly associated with burn T cells while cytokine-cytokine receptor interactions and T cell receptor signaling pathways are downregulated in burn T cells (Figure 4-Supplement Figure 1E).”</p><p>We chose not to use gene set enrichment analysis (GSEA) due to the experiment being a targeted scRNA-seq approach. In total, there were 256 genes following quality control that were captured in our experiment. Compared with GSEA analysis, GO and KEGG pathway analyses were more informative and identified enriched pathways that were more consistent with what is known in the literature.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>The authors should show the absolute numbers of each one of the T cell populations. That is done for total T cells, but I am asking about each one of them. The importance of that analysis is that when considering % a population decreases and another augments. Therefore it is hard to determine if there are more CD4 T cells or if their % just looks higher because there are fewer CD8 T cells, for example.</p></disp-quote><p>As addressed above under for Essential revisions 2:</p><p>We have added a supplemental figure (Figure 1-Supplement Figure 2) that includes cell per mm<sup>3</sup> for CD4 and CD8 T cell populations.</p><p>Lines 125-127:</p><p>“We did not see any significant differences in absolute numbers of CD4<sup>+</sup> or CD8<sup>+</sup> T cells between burn and non-burn skin. (Figure 1-Supplement Figure 2B-C).”</p><disp-quote content-type="editor-comment"><p>The authors could attempt to perform a gene set enrichment analysis with the sc RNA seq data to perhaps gain more information about additional functions of the T cell populations.</p></disp-quote><p>As addressed above under for Essential revisions 3:</p><p>We have added a supplemental figure that look at gene ontology (GO) and KEGG analyses for CD3 T cell scRNA-seq data, Figure 4-Supplement Figure 1.</p><p>Lines 214-221:</p><p>“Gene ontology (GO) analysis shows that T cell activation and positive regulation of cytokine production are associated with burn T cells while apoptotic processes are negatively associated with burn T cells. (Figure 4-Supplement Figure 1D). Lastly, KEGG analysis of CD3+ T cells shows Th17, Th1, and Th2 cell differentiation are highly associated with burn T cells while cytokine-cytokine receptor interactions and T cell receptor signaling pathways are downregulated in burn T cells (Figure 4-Supplement Figure 1E).”</p><p>We chose not to use gene set enrichment analysis (GSEA) due to the experiment being a targeted scRNA-seq approach. In total, there were 256 genes following quality control that were captured in our experiment. Compared with GSEA analysis, GO and KEGG pathway analyses were more informative and identified enriched pathways that were more consistent with what is known in the literature.</p><disp-quote content-type="editor-comment"><p>CD69 expression is highly different when comparing T cells from burned to non-burned skins. While we use it as a tissue residency marker, it also plays a function in lymphocytes. For example, CD69 appears to activate NK cells (PMID: 10447727). The authors could comment if the lack of CD69 alters the functions of skin-infiltrating T cells.</p></disp-quote><p>We added a section in discussion talking about relevancy of CD69.</p><p>Lines 337-343:</p><p>“It is also possible that this lack of CD69 in skin-infiltrating T cells may cause decreased regulation of T cell inflammatory responses due to fewer CD69+ Treg cells.<sup>49,50</sup> Downregulation of CD69 in mice has shown to increase Th17 differentiation and subsequent increase pro-inflammatory cytokines. Consistent with this, we saw a positive association of Th17 differentiation in our KEGG pathway analysis with burn tissue expression of RORC, a transcription factor associated with Th17 cells.<sup>50,51</sup>”</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>The work is very interesting with the caveats below.</p><p>– Figure 1. The authors calculate both percentage and number of cells/mm3 for CD3+, while for the subpopulations only the percentage is presented. Because percentages can be misleading, authors should also present the numbers/mm3 for the other populations (even if only as Supplementary Material).</p></disp-quote><p>As addressed above for reviewer 1:</p><p>We have added a supplemental figure (Figure 1-Supplement Figure 2) that includes cell per mm<sup>3</sup> for CD4 and CD8 T cell populations.</p><p>Lines 125-127:</p><p>“We did not see any significant difference in amount of CD4<sup>+</sup> or CD8<sup>+</sup> T cells between burn and non-burn skin. (Figure 1-Supplement Figure 2B-C).”</p><disp-quote content-type="editor-comment"><p>– The authors should include an example of the complete sequence of the gating strategy used in their flow cytometry (e.g. from FSCxSSC to the specific markers). This should be included in the Supplementary material.</p></disp-quote><p>We have added the gating strategy for all the T cells from FSCxSSC in Figure 1-Supplement Figure 2.</p><disp-quote content-type="editor-comment"><p>– In the first part of the manuscript, there is an emphasis on the pro-inflammatory state of T cells in the burned skin tissue samples, which show enhanced production of cytokines like TNFa and IFNγ. This is not investigated or discussed, however, when the results from scRNA-seq are presented. What happens to the expression levels of these and other cytokines (e.g. chemokines)? While the heatmap shows cluster markers, it would be good to have the cytokine expression levels shown as well and whether these are down- or upregulated after burn injury. This could be done by creating volcano plots where each T cell subset is compared (normal vs burn tissue samples), with specific cytokines indicated as well as the threshold of significance (p-value). Authors should take advantage of their rich dataset to present information about any relevant cytokines there (including chemokines) and not be limited to the ones analyzed by flow cytometry.</p></disp-quote><p>As addressed above for Essential Revisions 1:</p><p>We have added two supplemental figures showing the expression of cytokines by scRNA-seq in CD3+, CD8<sup>+</sup> and CD4<sup>+</sup> T cells. These are Figure 4-Supplement Figure 1 and Figure 5-Supplement Figure 1.</p><p>Lines 212-214:</p><p>“Lastly, we see that expression of effector molecules IFNΓ, TNF, NAMPT, GZMB, GZMH, and PRF1 is lower in burn compared to non-burn CD3+ T cells (Figure 4-Supplement Figure 1A-C).”</p><p>Lines 233-236:</p><p>“A closer look at effector molecules shows that burn CD4<sup>+</sup> T cells have lower expression of <italic>NAMPT</italic>, <italic>GZMA</italic>, <italic>PRF1</italic>, <italic>TNF</italic>, and <italic>CCL5</italic> compared to non-burn CD4<sup>+</sup> T cells (Figure 5-Supplement Figure 1A-B).”</p><p>Lines 241-243:</p><p>“We also saw that expression of <italic>NAMPT, TNF, IFNΓ, CCL4, and IL32</italic> were significantly lower in burn tissue CD8<sup>+</sup> T cells compared to non-burn CD8<sup>+</sup> T cells (Figure 5-Supplement Figure 1C-D)</p><disp-quote content-type="editor-comment"><p>– Although this is a descriptive work, the authors could explore more the meaning of their scRNA-seq data. A standard way to get an overall idea of which cellular processes and pathways are being stimulated or inhibited in large datasets like RNA-seq is the use of tools for pathway enrichment analysis. Therefore, authors should use their lists of genes affected by burn injury to perform a broader and unbiased analysis of how the function of these T cells is changing and how this may be related to processes like wound healing.</p></disp-quote><p>As addressed above under for Essential revisions 3:</p><p>We have added a supplemental figure that look at gene ontology (GO) and KEGG analyses for CD3 T cell scRNA-seq data, Figure 4-Supplement Figure 1.</p><p>Lines 214-221:</p><p>“Gene ontology (GO) analysis shows that T cell activation and positive regulation of cytokine production are associated with burn T cells while apoptotic processes are negatively associated with burn T cells. (Figure 4-Supplement Figure 1D). Lastly, KEGG analysis of CD3+ T cells shows Th17, Th1, and Th2 cell differentiation are highly associated with burn T cells while cytokine-cytokine receptor interactions and T cell receptor signaling pathways are downregulated in burn T cells (Figure 4-Supplement Figure 1E).”</p><p>We chose not to use gene set enrichment analysis (GSEA) due to the experiment being a targeted scRNA-seq approach. In total, there were 256 genes following quality control that were captured in our experiment. Compared with GSEA analysis, GO and KEGG pathway analyses were more informative and identified enriched pathways that were more consistent with what is known in the literature.</p></body></sub-article></article>